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INVESTIGATION OF INTERACTIONS OF THE RUBELLA VIRUS P150 REPLICASE
PROTEIN WITH HOST CELL PROTEINS IN INFECTED CELLS

by

SUGANTHI SUPPIAH

Under the Direction of Dr Teryl K Frey

ABSTRACT
Due to their simplicity, viruses require the assistance of host factors for various aspects of their
replication cycle. This study investigated the interaction of one of the two non-structural
replicase proteins of rubella virus (RUBV), P150, with cell proteins. RUBV forms replication
complexes for replicating its RNA in association with membranes of endosomes and lysosomes;
the thusly modified endosomes/lysosomes are termed cytopathic vacuoles or CPVs. In the first
study, a RUBV expressing a FLAG epitope-tagged P150 was used to co-immunoprecipitate
putative interacting cell proteins from an infected cell lysate fraction enriched for CPVs using
differential centrifugation. However, the only interacting protein identified was the companion
RUBV replicase protein P90. Thus, cell proteins do not bind with either sufficient affinity or in
stoichiometric amounts to be detected by this method and may not be a component of the virus
holoenzyme.

In the second study, a proline-rich region within P150 with three PxxPxR

consensus SH3 domain-binding motifs was investigated for its ability to bind cell proteins.
Substitution mutations (to alanine) of the two prolines were made in each of these motifs with
the finding that mutations in the first two motifs led to lower viral titers and a small plaque
phenotype with reversion to the wt sequence within one passage. Mutations in the third motif
had a wt phenotype and did not revert.

However, these mutations did not affect viral RNA

synthesis, suggesting that the importance of these motifs is in a later stage of viral life cycle, e.g.
virion assembly and release. To extend these findings, the proline hinge region with either the wt
or mutant sequence was expressed as a GST-fusion in human cells. Pulldown experiments
revealed specific binding with human p32 protein (gC1qR), which was previously shown to
interact with the RUBV capsid protein. Binding of p32 with P150 was confirmed. The function
of p32 in the RUBV replication cycle is unclear, but could involve virion assembly and release
or induction of apoptosis.
INDEX WORDS: Rubella virus, Proteomics, SH3 domain, Protein-protein interaction,
Cytopathic vacuole, Virus replication, P32

INVESTIGATION OF INTERACTIONS OF THE RUBELLA VIRUS P150 REPLICASE
PROTEIN WITH HOST CELL PROTEINS IN INFECTED CELLS

by

SUGANTHI SUPPIAH

A Dissertation Submitted in Partial Fulfillment of the Requirements for the Degree of

Doctor of Philosophy
in the College of Arts and Sciences
Georgia State University

2009

Copyright by
Suganthi Suppiah
2009

INVESTIGATION OF INTERACTIONS OF THE RUBELLA VIRUS P150 REPLICASE
PROTEIN WITH HOST CELL PROTEINS IN INFECTED CELLS

by

SUGANTHI SUPPIAH

Committee Chair: Dr. Teryl K. Frey
Committee: Dr. Margo A. Brinton
Dr. Phang C. Tai
Dr. Susanna F. Greer
Dr. Tom C. Hobman
Electronic Version Approved:
Office of Graduate Studies
College of Arts and Sciences
Georgia State University
May 2009

iv
DEDICATION
My deepest gratitude goes to my parents, Paremiswary and Suppiah, to whom I would
like to dedicate this dissertation to. It is their encouragement, support and dedication their whole
lives towards my education that allowed me to pursue my dreams and achieve my goal in a
science career. I would also like to thank my brother (Nithi), sister (Santhea) and my husband
(Matthew) for their endless moral support. Work done in the lab was also made easier with the
help of the members of the Frey lab (Wen Pin Tzeng, Heather, Jason and Yu Mei), who were
always there to help with the work itself and also being there for me as friends. I would like to
thank my mentor, Dr Frey, for giving me the opportunity to pursue my PhD in his lab, and also
believing in me and my work. Special thanks also go to the members of my committee (Dr
Brinton, Dr Tai, Dr Greer and Dr Hobman) who were willing to spend their time in helping me
achieve this degree.

v

TABLE OF CONTENTS
LIST OF TABLES

viii

LIST OF FIGURES

ix

CHAPTER
1. Introduction

1

History and clinical manifestations

1

Rubella virus (RUBV) and teratogenecity

3

RUBV genomic coding strategy and replication cycle

5

Virus and host protein interactions

7

Techniques employed in investigating virus and host factor interactions

10

Goals of the dissertation

17

References

19

2 . Specific aim 1: Investigating the interaction of host cellular factors with
RUBV non-structural replicase protein P150

26

Introduction

26

Materials and methods

28

Cells and virus

28

Preparation of virus infected cell lysates and immunoprecipitation

28

First dimensional isoelectric focusing (IEF)

29

Second dimensional SDS-PAGE and protein spot isolation

30

Concentration of RUBV cytopathic vacuoles (CPV) in cell lysates

30

vi
Western blot analysis

32

Electron microscopy of the P100 pellet to detect the presence of
CPVs

32

Immunofluorescence assay of P100 pellet with dsRNA antibody

32

Results

33

Identification of host proteins co-immunoprecipitating with P150 by
2D gel electrophoresis

33

Identification of host proteins co-immunoprecipitating with P150
following concentration of CPVs by 1D gel electrophoresis

36

Discussion

39

References

49

3. Specific aims 2 and 3: To investigate the importance of two SH3 binding
domains within the RUBV P150 nonstructural protein in the virus life cycle
and identify cell proteins with which they bind

70

Introduction

70

Materials and methods

72

Cells and virus

72

Mutagenesis of the Robo502 infectious cDNA clone

72

Construction of RUBV proline-hinge-GST fusion constructs

74

Analysis of PRR mutations created in Robo502

74

Analysis of PRR mutant RNA and DNA synthesis

76

Transfection with pEBG constructs and identification of interacting
cell proteins

78

Construction of hemagglutinin (HA) and c-myc epitope tagged p32
protein

79

Immunoprecipitation and Western blot analysis

80

vii

Immunofluorescence assay

82

RUBV replication in cells overexpressing p32

83

Results

83

Effect of mutagenesis of the putative SH3 binding domain in P150
on virus replication

83

Identification of host proteins that bind to Motifs 1 and 2 in the P150
PRR

86

Confirmation of the binding of host protein p32 to RUBV P150

87

Investigation of the function of p32 in the RUBV life cycle

88

Discussion

89

References

101

viii
LIST OF TABLES
Table 2.1. Mass-spectrometry identification of spots picked from a 2D gel (Fig. 2.3A)

58

Table 2.2. Mass-spectrometry identification of proteins co-immunoprecipitated with
P150 following cell fractionation to enrich for CPVs

68

Table 3.1. Sequence of Robo502 PxxPxR motif mutants after one passage in Vero cells

110

Table 3.2. RUBV replication in Vero cells over-expressing p32

123

ix
LIST OF FIGURES
Figure 1.1.

Schematic of RUBV virus life cycle

23

Figure 1.2.

Motifs within RUBV P150 and P90 nonstructural proteins

24

Figure 1.3.

Presence of cytopathic vacuoles (CPV) in RUBV infected cells

25

Figure 2.1.

Genomic diagram of Robo502-912

52

Figure 2.2.

Schematic showing the procedures used to identify host cell proteins
binding to RUBV P150

53

Figure 2.3A. Two-dimensional gel electrophoresis analysis of proteins
immunoprecipitated with RUBV P150

54

Figure 2.3B.

Close-up of 2-DE gel shown in Figure 2.3A

55

Figure 2.3C.

Close-up of 2-DE gel shown in Figure 2.3A

55

Figure 2.3D.

Close-up of 2-DE gel shown in Figure 2.3A

56

Figure 2.3E.

Close-up of 2-DE gel shown in Figure 2.3A

56

Figure 2.3F.

Close-up of 2-DE gel shown in Figure 2.3A

57

Figure 2.3G. Close-up of 2-DE gel shown in Figure 2.3A

57

Figure 2.4.

Lack of co-immunoprecipitation of Vps16 with P150 antibody

59

Figure 2.5.

Schematic showing the procedures used to fractionate cell lysates to
produce a fraction enriched for membranous organelles such as
endosomes, lysosomes and mitochondria plus, putatively, RUBV-induced
CPVs

60

Figure 2.6.

P150 distribution in subcellular fractions

61

Figure 2.7.

P150 distribution in high-speed centrifugation fractions

61

Figure 2.8.

Presence of Lamp2 lysosomal marker in high-speed centrifugation
fractions

62

Figure 2.9.

Electron micrograph of subcellular structures present in the P3 pellet
fraction

62

x
Figure 2.10. Immunofluorescence assay to detect the presence of dsRNA in the P3 pellet
fraction

63

Figure 2.11. Schematic showing the procedure to optimize solubilization of the P3
fraction prior to immunoprecipitation of P150

64

Figure 2.12. Solubilization of the P3 pellet with different lysis buffers

65

Figure 2.13. Distribution of P150 and P90 following solubilization of P3 fraction with
RIPA buffer

65

Figure 2.14. Co-immunoprecipitation of P150 and P90 following solubilization of P3
pellet

66

Figure 2.15. 1D SDS-PAGE of proteins immunoprecipitated with P150 in the P3
fraction of RUBV-infected cells

67

Figure 2.16. Comparison of SDS-PAGE of P150 and CPV1

69

Figure 3.1A. RUBV genomic organization and domains within the P150 nonstructural
protein

106

Figure 3.1B. Predicted consensus SH3 binding motifs within the P150 PRR

106

Figure 3.2. Multiple sequence alignment of proline rich region of RUBV from 7
genotypes

107

Figure 3.3. Viral titers in culture fluid from transfection plates and plaque morphologies

108

Figure 3.4. Viral titers in culture fluid from infected plates after passage 1 and plaque
morphologies

109

Figure 3.5. P150 and RNA production by Robo502 wt and mutant RNA

111

Figure 3.6. GST-PRR expression vector

112

Figure 3.7. Schematic of procedure used to identify proteins interacting with GST-PRR
fusion protein

113

Figure 3.8. Resolution of cell proteins interacting with pGST-PRR and pGST-PRRMUT 1+2 fusion proteins

114

Figure 3.9. Interaction of GST-PRR fusion proteins with host cell protein p32/HABP1/
gC1qR

115

xi

Figure 3.10. Co-immunoprecipitation of expressed P150 with endogenous p32

116

Figure 3.11.Co-immunoprecipitation of expressed p32 and P150 in RUBV-infected cells

117

Figure 3.12. Reciprocal co-immunoprecipitation of expressed P150 and p32

118

Figure 3.13. Colocalization of endogenous p32 with P150

119

Figure 3.14.Lack of co-immunoprecipitation of p32 with a P150 that has mutated
PxxPxR motifs

120

Figure 3.15. Expression of tranfected p32-c-myc

121

Figure 3.16 Intracellular localization of expressed c-myc tagged p32

122

1
CHAPTER 1
Introduction
History and clinical manifestations
Rubella, the disease, was first described in the 1700s by two German physicians, de
Bergan in 1752 and Orlow in 1758, the reason behind the synonym for the disease “German
measles” [1]. Rubella was initially not recognized as a separate disease entity; rather it was
associated with both scarlet fever and measles until 1814, when it was finally recognized as a
distinct disease and named “rothëln”. The physician who made this discovery was George de
Maton and subsequently the disease was renamed rubella by the Englishman Henry Veale in
1866, who described the original term, “rothëln”, as “foreign to the ears”
Rubella was thought to be a benign disease until an important discovery in 1941 by
Norman Gregg, an Australian ophthalmologist. He found that there was a correlation between
teratogenecity in newborn infants and contraction of RUBV by their mothers during pregnancy.
Specifically, this hypothesis was based on case studies collected by himself and his colleagues
showing a significant incidence of cataracts in babies born to mothers who were infected with
the virus during their pregnancy. The clinical manifestations of congenital rubella were more
extensive than the occurrence of cataracts. Some of the other manifestations that were
recognized were cardiac defects, deafness, retarded development leading to low birth weight and
microcephaly.
A rubella epidemic in the United States between 1964 and 1965, led to the recognition of
a variety of other congenital rubella defects. Approximately 20,000 cases of congenital rubella
syndrome (CRS) were recorded during those years and this vast number of CRS cases
contributed to the recognition of a variety of other defects that occurred as a result of congenital
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infection [2]. The occurrence of multiple defects was seen primarily when infection took place
during the first eight weeks of pregnancy. The fetus is at risk for congenital defects for up to
about twelve weeks of pregnancy and this includes an increased risk of death and stillbirths [3].
Some of the other complications associated with congenital rubella are purpura and
thrombocytopenia, enlarged liver and spleen, bone defects and central nervous system damage.
In contrast, complications are rare in children and adults who are infected by the virus.
The complications that do occur most usually involve arthritis and arthralgia, two forms of joint
complications that primarily affect adult women [4]. It is believed that the virus persists in
synovial cells and fluids of the joints. The live attenuated vaccine virus causes transient arthritis
in ~10% of adult female vaccinees. Why and how arthritis occurs, and primarily in women, is a
point of interest that has not been explored. Acute rubella can also lead to a post-infectious
encephalitis, which is rarely fatal [5]. As for the disease in infected children and adults, the
incubation period varies between 14 and 22 days. The earliest sign of infection is
lymphadenopathy [6] and, in some cases, fever. Rash appears after this incubation period and
typically lasts for three days (leading to another synonym for the disease, “three day measles”).
Rash usually starts on the face and spreads to the neck and trunk. Patients are a risk to naïve
individuals for about a week after the onset of rash. Serum antibodies appear at the time of rash
and virus can be isolated from nasopharyngeal washing from four to seven days after appearance
of the rash [6]. The route of horizontal transmission is respiratory, whereas vertical transmission
to the unborn fetus is due to a systemic infection of the mother, spreading through the placenta
and establishing a chronic infection in the fetus.
Thus far, immunization before pregnancy is the only preventive measure to counter the
occurrence of CRS. The successful development of rubella vaccines began when permissive cell
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culture systems used to isolate the virus were established in 1962 [7]. Two groups independently
identified cell lines that permitted the growth and isolation of rubella virus (RUBV); one was a
primary African green monkey kidney cell line developed by the Parkman group (Walter Reed
Army Institute of Research) and the other was a human amnion cell line developed by the Weller
and Neva group (Harvard School of Tropical Health). However, Parkman’s group was the first to
develop a live attenuated vaccine, HPV-77, in 1966 [8]. A derivative of vaccine (HPV-77/DE-5)
was the first RUBV vaccine licensed for usage in the United States in 1969. It was later replaced
with the RA27/3 vaccine strain when the vaccine program was expanded in 1979.
Rubella virus (RUBV) and teratogenicity
The exact mechanism by which congenital RUBV infection leads to CRS is unknown and
has been a point of contention. We do know that infection by the virus in the developing fetus is
persistent, facilitated by the undeveloped fetal immune system at the time of infection. Virus
penetration in the developing fetus is widespread, affecting many organs; however, the
percentage of infected cells in affected organs is low, on the order of 1 in 10,000 [9]. Necrotic
lesions are detectable, but not widespread, and immunopathological damage is nonexistent. The
primary observation is aborted fetuses with small organs or tissues size due to a reduced number
of cells.
As for the mechanisms that cause this pathology, there are several ideas stemming from
observations made from a variety of studies involving the effect of RUBV on infected culture
cells. Several studies have shown that cell lines infected by RUBV grow more slowly or stop
growing altogether after a few passages. This has been attributed to mitotic inhibition and
chromosomal breakage leading to disruptions in cell growth [10, 11] and/or the presence of an
uncharacterized protein in the supernatant of infected cells [12]. Another study showed that

4
infection of Vero (African green monkey kidney) cells by RUBV led to the progressive
disintegration of actin microfilaments [13] a finding that would lend support to mitotic inhibition
as a possible mechanism for cell cycle disruption because actin microfilaments are the basis for
the development of mitotic spindle.
Aside from the physical disruption of cell division, other studies pointed to the possible
role of interaction of RUBV proteins with host cell proteins as a contributing factor to the
occurrence of CRS. In particular, it was shown that one of the RUBV nonstructural replicase
proteins, P90, interacts with two host proteins, retinoblastoma (pRB) [14] and Citron-k Kinase
(CK) [15], which function in growth and differentiation and cell cycle regulation, respectively.
Either RUBV infection or over-expression of P90 [15] led to cell cycle arrest and the presence of
cells in the population exhibiting tetraploidy. Since it is known that the symptoms of CRS are
associated with retardation of organ development and genetic damage, it was speculated that
disruption of cell cycle by RUBV P90 may be a mechanism of the disruption of organogenesis.
A series of studies done by several different labs showed that RUBV induces apoptosis in
a variety of cell lines, pointing to the possible role of apoptosis in organ underdevelopment.
RUBV-induced apoptosis appears to be through both p53-dependent and independent pathways
[16-20].

In one cell line, overexpression of the virus capsid protein promoted induction of

apoptosis while in another cell line, overexpression of one of the replicase proteins, P150
appeared to be the inducer. Thus, the phenomenon of induction of apoptosis by RUBV is
complicated and likely cell line dependent. In this regard, Adamo and Zapata found that RUBV
does not induce apoptosis in primary human embryo fibroblasts (undifferentiated and
proliferating cells), but does so in human normal-term placenta chorionic villi explants [21]. The
finding was confirmed in a follow up study that used a line of primary fetal fibroblasts in
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comparison with a line of adult lung cells [22]. In this study, it was found that the adult cells
were programmed for apoptosis while in the fetal cells apoptosis was supressed. This finding
could potentially explain the persistence of RUBV in infected fetuses, but seems to rule out
apoptosis as a mechanism for the pathogenesis of CRS.
RUBV genomic coding strategy and replication cycle
RUBV virus is the sole member of the genus RUBV within the Family Togaviridae. The
single-strand RNA viral genome is 9,762 nt in length and encodes two open reading frames
(ORF’s) [23]. The genome has a 5’ cap structure [24], a 5’ open reading frame and a 3’ poly-A
tail [5], features that allow it to act as a messenger RNA when released into the host cell. The
genome is thus considered to be of “positive” or “plus-sense” polarity. The genome RNA also
has 5’ and 3’ cis acting elements (CAE) which have been shown to be important for virus
replication [25, 26]. A diagram of the RUBV replication cycle is shown in Fig. 1.1. Upon entry
of the virus into a host cell, which is thought to occur via receptor mediated endocytosis [27],
cell-viral membrane fusion followed by release of the genome from the capsid occurs. Once
released into the cytoplasm, the genome serves as an mRNA from which the ORF at its 5’ end is
translated to produce the viral nonstructural protein (NSP) precursor, P200, that is cleaved to
generate two mature nonstructural proteins (NSPs), P150 and P90. P150 and P90 are located at
the N- and C-terminal ends of P200, respectively. The protease that cleaves the P200 precursor
lies at the C-terminus of P150. This nonstructural (NS) protease is a cysteine protease, with
residues Cys-1151 and His-1272 as the catalytic dyad [28, 29], that catalyzes the cleavage of
P200 at a single site, between the Gly-1301 and Gly-1302 residues. The protease domain is the
only domain within P150 whose function has been experimentally proven. The other domains
within RUBV P150 are the methyl/guanylyltransferase domain, the proline rich or hypervariable
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domain, and the X-domain, which shares homology with adenosylribose phosphatases (ADPribose-1-phosphatase) of cells and other RNA viruses [30] (see Fig. 1.2 for non-structural protein
predicted motifs). The P90 nonstrucural protein contains the virus helicase domain [31] and the
RNA dependent RNA polymerase (RDRP) domain [32]. The helicase domain has been shown
to have ATPase activity while mutagenesis of the catalytic GDD domain characteristic of
RDRP’s abrogates infectivity.
In the infected cells, the plus strand genomic RNA serves a dual purpose. First, it serves
as a messenger RNA as discussed above; and second, it serves as the template for the synthesis
of a minus-strand genomic complement. The minus-strand RNA is the template from which
more genomic RNA is synthesized (40S) and from which a subgenomic mRNA is transcribed.
The subgenomic RNA contains sequences from the 3’ end of the genomic RNA, which encode
the 3’ proximal ORF. The RUBV structural proteins are translated from this subgenomic RNA
to produce a p110 polyprotein containing the viral capsid and glycoproteins E2 and E1, in that
order [24, 33]. During translation of the polyprotein, translocation into the ER occurs mediated
via signal peptides present in the amino termini of E2 and E1, and cleavage ensues within the ER
lumen to produce the mature structural proteins [34, 35]. Cleavage of the structural polyprotein
is mediated cotranslationally by cellular signalase [35] present in the lumen of ER, so that the
p110 precursor is not observed in infected cell lysates.
P200 appears to catalyze synthesis of the minus strand RNA from the genomic RNA
while P150 and P90 catalyze synthesis of the genomic and subgenomic plus strand RNAs [36].
Thus, proteolytic cleavage controls RNA replication. RNA replication occurs in so-called
replication complexes (RCs) contained in spherules that appear on the inner surface of
endosomes and lysosomes in infected cells [37, 38] (see Fig. 1.3). These modified endosomes
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and lysosomes in infected cells have been termed cytopathic vacuoles or CPVs. CPVs are
approximately 0.6-2.0 µm in diameter and the membrane spherules that line the CPVs at regular
intervals are 50 nm in diameter. The presence of active RCs in these spherules has been
demonstrated using antibodies against double stranded RNA, an intermediate in the replication
process, via immuno-electron microscopy [39, 40]. Biogenesis of CPVs leads to a redistribution
of some of the organelles in the infected cell. Specifically, the RER, Golgi, and mitochondria are
recruited to the area surrounding the CPV. The subgenomic RNA is translated in association
with the RER and the direct translation of this RNA following its synthesis is supported by the
observation that thread-like ribonucleoproteins structures extend from the base of the CPV
spherules and form connections with RER [41, 42]. Virion budding occurs into this Golgi and
therefore the presence of Golgi at the location of viral genome synthesis would facilitate the
packaging of mature virions in a compartmentalized region of the infected cell. The reason for
the recruitment of mitochondria is less clear, although they could provide a localized supply of
ATP.
Virus and host protein interactions
Viruses require the assistance of host factors in general for various aspects of their
replication cycles. This is because the simplicity of the viral genome does not allow for the
coding of large numbers of complex proteins and as obligate intracellular parasites, viruses take
advantage of what the cell has to offer. For example, RNA viruses that replicate in the cytoplasm
and use viral encoded RNA dependent RNA polymerase (RdRp), have to modify the host
cytoplasmic environment as normal eukaryotic RdRp functions occurs in the nucleus. As a
result, host factors such as those involved in translation may be used as part of the viral
replicative machinery. Examples of such interactions will be discussed later.
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There are different ways in which host cellular factors play a role in virus RNA
replication. Some of these interactions will be described in more detail later. Host cellular factors
have been shown to bind to both the viral genome as well as to the enzymatic replication
complex to promote template recognition, template switching from translation to replication as
well as promoting proper assembly of the replication complex. Intracellular membranes and the
cytoskeleton also play important roles in helping to target virus proteins to the appropriate sites
of replication and RNA replication of all plus-strand RNA viruses occurs in association with
membranes [43-45]. Virus components could also interact with host cellular factors involved in
signaling pathway. Some of these signaling pathways affect the cell cycle as well as the innate
immune response of the host cell. Since our work is on RUBV, which is a positive sense RNA
virus, some examples of host cellular factors interacting with other positive strand RNA viruses
will be further discussed as some of these interactions might have functional parallels in RUBV
infected cells.
The classic example of virus-host interaction is that of host proteins combining with the
RDRP subunit of bacteriophage Qβ to comprise the complete enzyme complex [46]. Studies
found that three host proteins EF-Tu, EF-Ts and ribosomal protein S1 were a part of the
bacteriophage holoenzyme. These host components are part of the translation machinery of the
cell. These host cellular factors function in the holoenzyme by conferring specificity to template
binding. Studies involving bacteriophage Qβ replicase protein have shown that subunits S1, EFTu and EF-Ts. enable template recognition of positive and negative strand RNA during the
process of replication [47].

Additionally, a fourth host protein, HF1 (ribosome-associated

protein) binds to the 3’ end of the genome to direct the synthesis of negative strand RNA [48].

9
This is a good example of how a virus uses host cellular factors to compensate for the lack of
virus factors important for its replication.
Subsequently, appropriation of host cellular factors involved in host cell translation has
been found to be quite a common theme among different viruses. For example, the binding of
eIF-3 (translation elongation factor 3) to both the RDRP and the 5’ and 3’ untranslated regions
(UTRs) of the genomes of positive strand RNA viruses has been found to occur [49,50]. Studies
done with brome mosaic virus (BMV) RDRP purified from infected barley cells [49] reported
the copurification and enrichment of eIF-3. Addition of eIF-3 to BMV RdRp led to a 3-fold
increase of minus strand RNA synthesis in vitro. eIF-3 has also been shown to associate with the
RDRP complex of poliovirus (3AB-3CDpro) [50]. This interaction was hypothesized to be
important for the binding of the replication complex to the 5’ cloverleaf of the genome in the
replicative intermediate to facilitate the synthesis of genomic RNA from the minus strand
template. In a study of host proteins binding to West Nile virus (WNV) RNA, it was found that
the host translation factor eEF1α bound to the 3’ stem loop of the genomic RNA

[51].

Mutational analysis of this binding site caused a decrease in production of minus strand RNA,
strongly pointing to the role of eEF1α in facilitating minus strand synthesis [52]. In another
study involving the non-structural protein NS5A of bovine viral diarrhea virus (BVDV) that has
a role in BVDV replication, interaction with translation elongation factor eEF1α was
demonstrated [53]. This interaction was shown to be specific for BVDV NS5A protein and
occurred consistently among the different BVDV isolates. This finding was relevant because the
NS5A protein of BVDV is the most variable among the many BVDV isolates [54] and the
conserved interaction of eEF1α with NS5A was highly indicative of the role of eEF1α in BVDV
replication.
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Techniques employed in investigating virus and host factor interactions
The preceeding discussion of some studies on the identification of host proteins involved
in virus RNA replication reveals that three main techniques have been employed: isolation of
pairing partners of expressed virus replicase proteins or domains of virus replicase proteins, use
of viral RNA sequences as bait for binding of cell proteins in cell lysates, and isolation of
replication complexes and replicase proteins from infected cells to identify cell proteins which
co-purify. With the expansion of the sequence database, bioinformatics tools have been
developed to predict specific interactions.

For example, the interaction of pRB and P90,

described above [14], was originally predicted by bioinformatics algorithms using consensus
sequences. Finally, gene deletion libraries in yeast and genome wide siRNA knockdown
techniques have been employed to identify cell proteins essential for virus replication.
Representative examples will be used to illustrate the use of each of these techniques,
concentrating on studies that utilized RUBV or an alphavirus, the nearest relatives of RUBV.
1) Detection of protein pairing partners through expression of proteins and/or protein
domains. The yeast two-hybrid system has been used extensively for the identification of
protein pairing partners. In this system, the protein of interest is expressed in yeast as a bait to
identify pairing partners. The interaction of the bait protein with a binding partner (prey)
expressed from a library leads to the transcription of a reporter gene downstream of an activating
sequence resulting in colony selection and identification. In one such study, the interaction of
RUBV capsid with the mitochondrial p32 protein was discovered [55]. RUBV capsid was used
as bait to screen a CV1 (monkey cell) cDNA library and a strong interaction of capsid protein
with p32 was found. The interaction of these two proteins were confirmed through coimmunoprecipitation (both in-vitro and in-vivo) and immunofluorescence assays (IFA).

A
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follow up of this work confirmed that p32 bound to RUBV capsid through two clusters of
arginine present at the capsid’s N-terminus. Studies also showed that over-expression of capsid
led to the clustering of mitochondria in the perinuclear region of cells. Mutations introduced in
the p32 binding sites on capsid led to decreased mitochondrial clustering, implying that the p32capsid interaction is important for this phenomenon to occur. Virus induced mitochondrial
clustering is a hallmark of RUBV infection [1] and this study suggested that p32 was directing
the clustering of mitochondria to sites of virus production in association with capsid. The
researchers also found that mutation of the p32 binding site on capsid led to a decrease in
subgenomic RNA production, lower viral titers and altered plaque morphology. The P90-citron
K kinase interaction discussed above was also discovered by the yeast two hybrid system using
P90 as bait [15].
In another study done to identify binding partners of RUBV capsid, the capsid protein
was over-expressed as a GST fusion protein from a mammalian expression vector (pEBG
expression vectors) [56]. The GST-capsid fusion protein expressed in transfected COS cells were
isolated with its binding partners on gluthathione-agarose beads and high abundance cell
proteins were identified by gel electrophoresis and mass-spectrometry analysis. Using this
method, researchers identified poly (A)-binding protein (PABP) as a binding partner of capsid
protein. This interaction once again was verified via both in-vitro and in-vivo methods. PABP is
a host protein that plays an important role in the regulation of translation [57]. The researchers
postulated that the interaction of capsid protein and PABP may be important in the regulation of
host translation by RUBV. By sequestering PABP, researchers hypothesized that translation
would be inhibited and that this would favor the transition of viral genome from viral translation
to packaging.
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2). Identification of cell proteins interacting with viral RNA sequences. This technique is
based on the hypothesis that binding of host proteins to the cis-acting elements in viral RNA
species facilitates specific binding of the viral RDRP to its template. Host proteins act as a
bridge to recruit viral RNA to the RdRp and possibly are part of the enzymatically active
ribonucleoprotein complex. In addition, host proteins that bind to different cis-acting elements
(i.e at different ends of the same strand or on different strands) can regulate template switching.
Using radiolabelled RNAs corresponding to cis-acting elements as probes, the binding of host
proteins to 5’ and 3’ cis-acting elements of genomic and anti-genomic RNA have been detected
and confirmed using gel mobility shift and UV crosslinking assays. Subsequently, using
sequential chromatography or RNA affinity columns followed by mass spectrometry, host
proteins that interact with specific RNA sequences can be identified.
These techniques were used in the studies mentioned above that demonstrated that eEF1α binds to the 3’ cis-acting element of the West Nile virus (WNV) genomic RNA [51], similar
techniques led to the identification of TIA-1 and TIAR binding to the 3’ stem loop of the WNV
minus strand RNA [58, 59]. TIA-1 and TIAR are multifunctional RNA binding proteins that
shuttle between the nucleus and cytoplasm and have roles in translation and RNA splicing. The
effect of these host proteins on WNV replication was evaluated in TIAR and TIA-1 knockout
murine embryo fibroblast cell lines. Results showed that WNV replication was impaired in the
TIAR knockout cell line but not in the TIA-1 knockout cell line. Later studies showed that
mutations of TIAR/TIA-1 binding sites made in the 3’ stem loop of the WNV minus strand in an
infectious clone negatively affected plaque size, genomic RNA levels and virus production [60].
It was concluded that the binding of TIAR/TIA-1 to the 3’ stem loop of the WNV minus strand
played an important role in the synthesis of genomic RNA and it was hypothesized that this
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binding promoted RDRP specific recognition of the 3’ end of the minus strand template and also
stabilization of the replication complex. The interaction of the 3’ stem loop of WNV minus
strand RNA with TIAR/TIA-1, which are components of stress granules [61], was found to
confer resistance to the formation of stress granules in infected cells. This study suggested that
the interaction of the WNV negative strand 3’ stem loop with TIAR facilitated virus genome
synthesis and inhibited the formation of stress granules, causing host translation machinery not
to be shut down.
In RUBV, several host proteins have been found to associate with stem-loops at the 5’
and 3’ ends of the genome strand. Calreticulin, a calcium binding protein was found to associate
with a stem loop at the 3’ end of the genome RNA [62]. Only the phosphorylated form of
calreticulin bound to the viral RNA. However, a subsequent mutagenesis study failed to confirm
that calreticulin binding to this stem-loop was important for replication [25]. In another study,
the La autoantigen was found to interact with the 5’ stem loop of RUBV genome RNA [63]. La
antigen is an RNA binding protein that is important for initiation and termination of RNA
polymerase III [64] and is involved in autoimmune disease as a target of the immune system.
The specificity of the RNA-protein interaction between the 5’ stem loop (+) of RUBV and the La
autoantigen in samples that were positive for endogenous La antigen or recombinant La antigen
together with the observed inhibition of this complex formation in serum containing anti-La
antibody, demonstrated the functional relevance of this binding. Also, patients who were
infected with RUBV had an increase in anti-La antibody. This increase is thought to be a
contributing factor to the arthritis and arthralgia seen in adult female patients.
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3). Isolation of host proteins binding to viral proteins in virus infected cells
Isolation of viral replicase proteins from infected cells by immunoprecipitation and
identification of co-immunoprecipitating host proteins that interact with virus proteins of interest
is an alternate technique. This approach has been used in three recent studies on interaction of
host proteins with the replicase proteins of Sindbis virus (SINV), a member of the alphavirus
genus. These studies used virus that expressed a GFP-tagged nonstructural replicase protein
nsP3; the presence of this tag did not interfere with virus replication. In one study, isolation was
done following a time course from 2 to 10 hours post-infection and interacting host proteins over
the time course were identified [65]. The control used for this experiment was free GFP that was
expressed from a subgenomic RNA. Using this method, cellular redistribution that would occur
as a result of virus infection was taken into account. Immunoaffinity purification from cell
lysates was done with magnetic beads coated with polyclonal anti-GFP antibody and copurifying cell proteins were resolved by one dimensional SDS-PAGE and then identified by
mass-spectrometry analysis. Once the identities of these proteins were determined, their
interaction with nsP3 was confirmed using additional methods such as reciprocal coimmunoprecipitation and co-localization. Candidate interacting proteins were identified that
interacted with nsP3 throughout the time course of infection (G3BP proteins) and as well as only
during the late infection period (14-3-3 proteins). G3BP proteins have been shown to be
involved in a variety of cellular processes including RNA metabolism, translation and assembly
of stress granules. They also have a role in transport of RNA in and out of the nucleus [66-68].
Since SINV shuts down endogenous cell translation and redirects the translation machinery to
the production of virus proteins, it was postulated that G3BP proteins may a play a role in the
regulation of SINV translation possibly including sequestering host RNA in order to facilitate
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virus translation. The 14-3-3- proteins consist of a group of proteins that are known
phosphoserine-binding adapter proteins involved in cellular signaling. Since this interaction
occurs later during virus infection, it was suggested that a phosphorylation event involved in host
translation shutoff, shutoff of minus strand synthesis or other signaling cascades could be a
functional result of this interaction.
Two additional studies were done to investigate host proteins that interacted with the
nonstructural replicase proteins of Sindbis virus. In one of these studies, nsP3 protein tagged
with GFP expressed from a Sindbis replicon (without structural proteins) was employed to study
the localization of nsP3 and its association with host cell proteins [69]. In this study, the
interaction of nsP3 with host proteins was studied in both mosquito cells (mosquitoes are vectors
for this virus) and vertebrate cells (hosts that are acutely infected). Rather than
immunoprecipitation as in the previously described study, control and nsP3-GFP expressing cells
were homogenized and sedimented on sucrose gradients to fractionate cells components.
Fractions containing different membranes were clearly separated and nsP3 was found in both
nuclear and plasma membranes as well as in endosome-like vesicles suggesting multiple roles
for nsP3: one function that is associated with replication complexes found in conjunction with
the other non-structural proteins in the plasma as well as endosomal membranes, and another
function that is possibly related to regulatory processes associated with its presence near the
nuclei. Using this fractionation method, the researchers were also able to identify interactions
between the G3BP1 and G3PB2 proteins, as well of other cell proteins (including two other
stress reponse proteins, YBX1 and HSC70), with nsP3 by co-immunoprecipitation in both the
membrane and nuclear fractions. The researchers were also able to identify the presence of
dsRNA in the membrane associated fraction using Western blot analysis, indicating that
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replication occurred in association with membranous structures as previously reported. In
mosquito cells, Rasputin, an insect homolog of G3BP protein, interacted with nsP3 associated
with a membrane fraction (endosome, microsome and plasma membrane). This finding indicated
the conserved nature of this interaction in both vertebrate and invertebrate cells.
In the third study on the interaction of host cell proteins with the SINV replication
complex, differential expression of proteins in cytoplasmic membrane fractions of infected and
uninfected cells was compared [70]. Two-dimensional difference in-gel electrophoretic (2DDIGE) analysis was performed using Cy3 and Cy5 labelled proteins from membrane fractions of
infected and uninfected cells. This study led to the identification of the heterogenous nuclear
ribonuclear protein K (hnRNP K) as a cell protein enriched in cyoplasmic membrane fractions
from infected cells. It was subsequently shown that hnRNP K co-immunoprecipitated with the
SINV nonstructural proteins and the subgenomic (but not the genomic) RNA and it was
hypothesized that it was part of the RC and played a role as in regulating the ratio of genomic
and subgenomic RNA synthesis and subsequent subgenomic RNA translation.

While this

method was a good method for identifying host proteins that were enriched in certain cellular
fractions during infection, it was not a good way to identify interacting proteins that did not
change in abundance at a specific location as a result of infection.
4). Genomic scans. A cell genome wide mutation approach to identify host genes involved in
virus replication was done in yeast cells which were found to accommodate the replication of
brome mosaic virus (BMV), a plant virus. In this study, using a single-gene deletion mutant
library, the effects of many host proteins on BMV replication were rapidly analyzed [71]. It was
found that the absence of approximately 100 genes either inhibited or stimulated BMV RNA
replication and gene expression by 3 to more than 25 fold. One observation worth noting was
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that deletion of the gene encoding an acyl-CoA binding factor involved in membrane
sphingolipid biosynthesis inhibited BMV replication by 25 fold. Such an observation gives
validation to the data because of the importance of cellular membranes as virus replication
complex formation sites. While fibroblast lines from mouse knock out lines can be used for the
same end, recently siRNA knockdown libraries have been used to identify genes important in
virus replication in commonly used cell culture lines. For example, an siRNA screen was used
to identify 305 genes in human cells that affect WNV replication [72]. Although this strategy is
powerful, it identifies genes that function in any aspect of the virus life cycle, including some
with epistatic rather than direct effects.
Goals of the dissertation
The focus of my dissertation research was to continue the research on virus-host
interactions in RUBV-infected cells, specifically interactions that involve binding of host factors
to the RUBV P150 non-structural replicase protein, a protein that had not previously been
investigated in this regard.
Specific Aim 1. To identify host cell proteins interacting with P150 in RUBV-infected cells
by co-immunprecipitation.
Recently, a RUBV infectious clone expressing a P150 tagged with epitopes such as FLAG, HA,
or c-myc became available in our lab allowing us to use commercially available reagents to
immunoprecipitate tagged P150 from infected cells and to co-immunoprecipitate interacting
cellular proteins. Therefore, the initial goal of this Specific Aim was to identify coimmunoprecipitating cell proteins with the subsequent goal of characterizing their role in RUBV
replication.
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Specific Aim 2. To determine if the binding of cell proteins with the P150 proline rich
region plays a role in virus replication.
A proline rich region was previously identified in the P150 non-structural replicase protein that
extends from residues 716 to 782 (out of 1301 amino acids). Proline rich domains in cell proteins
often function as adaptor regions that mediate protein-protein association and are often involved
in interactions between intermediates in cellular signaling cascades.

Commonly, these

interactions are via SH3 domains and the P150 proline rich region contains three putative Class
II SH3 binding motifs with the consensus sequence PxxPxR. To test the hypothesis that proteinprotein interactions mediated by these motifs were important during virus infection, mutations to
disrupt putative binding were introducted into a RUBV infectious cDNA clone to see if a change
in phenotype resulted and to characterize that phenotype.
Specific Aim 3. To investigate the cell proteins bound by the P150 proline rich region.
The P150 proline rich region was expressed as a GST fusion protein and used to specifically
isolate interacting cell proteins in transfected 293-T human kidney cells. Mutations predicted to
interrupt the interactions mediated by the PxxPxR motifs were introduced into the fusion protein
to ascertain the specificity of the interaction. Proteins which specifically bound to wt P150 and
not the mutant were to be identified by mass spec, their interaction with P150 confirmed and
their importance in virus replication to be analyzed.
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Figure 1.1. Schematic of RUBV virus life cycle.
RUBV virus enters its host via receptor mediated endocytosis. Upon entry into the host cell,
diassembly of capsid occurs, releasing the plus strand RNA genome into the cytoplasm. The
viral plus strand genome acts as an mRNA, which then is translated to produce the virus nonstructural polyprotein (NSP). The NSP is processed by the viral protease to produce separate
proteins referred to as P150 and P90 (RNA dependent RNA polymerase). Together, the proteins
P150 and P90 form a replication complex that goes on to synthesize the minus strand RNA
intermediate and more plus strand RNA. Following transcription at the sub-genomic promoter of
the minus strand RNA, structural proteins (SP) are produced. SP is then processed by cellular
proteases to form the mature structural proteins, capsid protein, and glycoproteins E2 and E1.
These proteins function in packaging the plus strand genome to produce mature RUBV virus
particles.
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Figure 1.2. Motifs within RUBV P150 and P90 nonstructural proteins.
Various domains present within the P150 nonstructural protein (1301 aa) are: MT
(methyltransferase), aa 63-132; HVR (hypervariable region), aa 693-799; XD (X domain/ADP
phophatase like motif), aa 817-985 and NP (nonstructural protease), aa 1000-1299. Domains
present within the P90 nonstructural protein (aa 1302-2116) are: HEL (helicase), aa 1334-1585;
RdRp (RNA dependent RNA polymerase), aa 1595-2115.
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Figure 1.3. Presence of cytopathic vacuoles (CPV) in RUBV infected cells.
Cells infected by RUBV appear to have modified endosomes and lysosomes termed cytopathic
vacuoles or CPV. CPVs are 0.6 to 2 µm in size and form 50 nm spherules that line the vacuole
membranes at regular intervals. The above images are from a review published by Risco et. al.
[44]. The arrows indicate the presence of spherules within CPVs. The CPVs are often
surrounded by cisternae of rough endoplasmic reticulum (RER) and mitochondria (mi).
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CHAPTER 2
Specific aim 1: Investigating the interaction of host cellular factors with RUBV nonstructural replicase protein P150
Introduction
Positive strand RNA viruses have long been known to form RNA replication complexes
(RCs) in association with intracellular membranes in the host cell, a subject that has been
extensively reviewed [1, 2]. These so-called “virus factories” are formed in association with
various intracellular membranes. The viral factories for different virus families are associated
with different intracellular membranes. Viruses from the Family Flaviviridae, such as hepatitis C
virus (HCV) and yellow fever virus (YFV), form RCs that are contiguous with or derived from
the rough endoplasic reticulum (RER) and Golgi apparatus [2, 4], while viruses from the Family
Togaviridae, such as RUBV and Sindbis virus (SINV), form RCs within so-called cytopathic
vacuoles (CPVs) that are modifications of late endosomes and lysosomes [2, 5-7]. The
association of the RC with an intracellular membranous structure has been suggested to be
important for the following reasons. Firstly, intracellular membranes provide a surface for the
anchoring of RC. The anchoring of RCs to membranes is usually achieved by the attachment of
the RC to the membrane through hydrophobic domains of virus replicase proteins. This
mechanism has been shown for the non-structural protein nsP1 of Semliki Forest virus (SFV), a
togavirus that was found to anchor the viral RCs to membranes of endocytic organelles via its
hydrophobic domain [8]. The assembly and anchoring of the RC to membrane structures can be
directed by host factors. As an example, it was found that replication of brome mosaic virus
(BMV) was blocked when mutation of the yeast gene YDJ1 was made [10]. YDJ1 was shown to
be important in early steps in the BMV virus replication cycle which included targeting of virus
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non-structural proteins to the membrane and stabilization of RC. Another piece of evidence
showing the importance of host membranes in establishing RCs was obtained in a study that
involved mutations of the OLE1 gene in yeast cells that harbour brome mosaic virus (BMV)
[11]. OLE1 encodes ∆9 fatty acid desaturase and is important for the formation of membranous
structures. Mutation of this gene in BMV infected yeast cells affected early viral replication
steps preceding the synthesis of virus negative strand RNA. From these finding, it is quite
evident that intracellular membranes do play a viral role in the formation of viral factories
containing RCs.
Formation of RCs that are located on and even enclosed within membranous structures of
host cells are also important in creating a “safe haven” for the replicating RNA virus as the
double stranded RNA (dsRNA) intermediates is targets of the host innate immune response [12].
dsRNAs produced as viral replication intermediates are recognized by different host patternrecognizition receptors (PRRs) [13]. These PRRs recognize conserved molecular motifs called
“pathogen-associated molecular patterns” or PAMPs. Two classes of PRRs play a role in
recognition of viral dsRNA intermediates, a class of RNA helicases including RIG-I and MDA5, and a Toll-like receptor (TLR), namely TLR3 [13]. Both of these classes of PRR induce type 1
interferon responses (through different pathways) and pro-inflammatory cytokines that counter
virus infection of both the cell and organism. However, the helicases function by recognizing
intracellular dsRNA, while TLR3 primarily recognizes exogenous dsRNA.
Although numerous studies have been done that show the association of virus RCs with
intracellular membranes, the exact mechanism of targeting and morphogenesis of RCs is mostly
unknown. Not much is known either about the host factors that are physically present in active
RCs simply because the isolation of such membrane bound complexes while preserving their
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enzymatic integrity is difficult to accomplish. In this study, co-immunoprecipitation with tagged
RUBV nonstructural replicase protein P150 was employed to identify host proteins interacting
with this protein.

At first, P150 was immunoprecipitated from a post-nuclear supernatant

prepared from lysates of RUBV-infected cells. Subsequently, immunoprecipitation was done
from a cell fraction enriched for cytoplasmic organelles (including the endosome and lysosomederived CPVs) by differential centrifugation [14]. While this modification was initially made to
decrease background, we felt it was also more promising for identifying cell proteins directly
associated with RCs. This is the first study of host proteins associated with RUBV nonstructural
proteins that was done. These studies were performed in RUBV infected cells.
Materials and methods
Cells and virus
Vero cells, a continuous line of African green monkey kidney cells obtained from the
American Type Culture Collection, were grown and maintained at 35oC in a humidified
atmosphere with 5% CO2 in Dulbecco’s modified Eagle’s medium (DMEM) containing 5% fetal
bovine serum (FBS) and gentamicin (10 µg/ml). For infection, Vero cell cultures at ~80%
confluence were infected at a multiplicity of infection (MOI) of 1 plaque forming unit (pfu)/cell
with RUBV derived from the Robo502 infectious cDNA clone (Robo502 virus)[15] as control or
Robo502-912 virus, which bears a FLAG-epitope tagged P150, derived from the Robo502-912
infectious cDNA clone (Wen-Pin Tzeng, unpublished data).
Preparation of virus infected cell lysates and immunoprecipitation
Ten 100 mm culture plates of Vero cells that had been infected with Robo502 or
Robo502-912 virus for 48 hours were washed twice with ice-cold phosphate buffered saline
(PBS) and the cells were lysed with modified RIPA buffer [10 mM Tris-HCl pH 7.4, 100 mM
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NaCl, 1 mM EDTA, 1 mM EGTA, 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X-100 and
1X broad range protease inhibitor (ROCHE)]. The cells in the lysis buffer were incubated on ice
for 20 minutes before centrifugation at 12,000 rpm (Beckman coulter, JA 20 rotor) for 5 minutes
to remove nuclei and cellular debris. Ten ml of clarified lysate were incubated with 1 ml of
prewashed (PBS + 0.1% Triton X-100) anti-FLAG monoclonal antibody-conjugated agarose
beads (SIGMA) for 2 hours at 40C. The bound beads were washed three times with lysis buffer.
and were eluted with 2 ml of a 100 µg/ml solution of FLAG peptide (SIGMA) and the eluted
proteins were precipitated by addition of three volumes of ice cold acetone and incubation at 20oC for 1 hour [16]. Precipitated proteins were collected by centrifugation at 12,000 rpm
(Beckman coulter, JA 20 rotor), the acetone was removed, and the precipitated protein pellet was
allowed to air dry for ~10 minutes. Precipitated proteins were resuspended in 250 µl of 2D
rehydration buffer (7M urea, 2M thiourea, 4% CHAPS, 2% Pharmalyte [broad range pH 3-10]
and 40mM dithiothreitol; the latter two components were added to the rehydration buffer just
before use) and incubated at 30oC for 1 hour. An aliquot was subjected to SDS-polyacrylamide
electorphoresis (SDS-PAGE), transferred onto nitrocellulose membrane (Whatman) using 1X
transfer buffer (100 ml 10X transfer buffer [250 mM Tris, 1.92M glycine], 200 ml 100%
methanol, and 700 ml deionized water) at 100V for 1 hour in a mini-Protean II apparatus
(Biorad) and the Western blot probed with anti-FLAG antibodies (Sigma Aldrich) to confirm the
presence of FLAG-tagged P150 in the sample.
First dimensional isoelectric focusing (IEF)
A 250 µl aliquot of resuspended immunoprecipitated proteins was applied to a 13 cm
Immobiline strip (GE-Healthcare Life Sciences) with a nonlinear pH range of 3-10. The strip
was covered with 1 ml of Dry Strip cover fluid (GE-Healthcare Life Sciences) and isoelectric

30
focusing was done using an IPGphor apparatus (Amersham) as follows: Rehydration for 16
hours at 30V; Increase to 200 V and hold for 1 hour; Increase to 500 V and hold for 1 hour;
Increase to 1000 V and hold for 1 hour; Gradient for 30 minutes to 8000V; and Gradient for
32,000 V/hr up to 8000V. After isoelectric focusing, the strips were prepared for second
dimension separation by SDS-PAGE.
Second dimensional SDS-PAGE and protein spot isolation
The IEF strips were removed from the IPGphor and washed for 15 minutes each with 10
ml of 1% DTT and 10 ml of 4% iodoacetamide. The strips were then transferred to the top of a
10% SDS-PAGE gel (10% acrylamide, 0.38 M Tris pH 8.8, 0.1% SDS, 0.1% ammonium
persulfate). Agarose (0.5%) was used to seal the strips. Following electorphoresis, the gels were
stained with Deep Purple Total protein stain (GE-Amersham) and scanned using a Typhoon
imager (GE Healthcare) at an excitation length of 528 nm. The scans were analyzed using Image
Master Platinum 2.0 software (GE-Amersham) and spots unique to the Robo502-912-infected
cells lysate were isolated using an ETTAN spot-picker. Protein plugs were stored in 4oC until
analysis was done by trypsin digestion and Matrix Assisted Laser Desorption Ionisation mass
spectrometry (MALDI-TOF) (Morehouse School of Medicine).
Concentration of RUBV cytopathic vacuoles (CPV) in cell lysates
A previously described method for concentration of a lysosomal fraction from cell lysates
[14] was used to concentrate RUBV CPVs from Robo502 and Robo502-912 virus-infected cell
lysates. Ten 100 mm culture plates of Vero cells infected with Robo502 or Robo502-912 virus
(MOI ~1 pfu/cell) were harvested at 48 hours post-infection by using a cell scraper after being
washed twice with PBS. The detached cells were collected in cold fractionation buffer (10 mM
tris(hydroxymethyl)aminomethane/acetic acid pH 7.0, 250 mM sucrose) and washed twice in
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fractionation buffer by low speed centrifugation. Cold fractionation buffer was also used in the
following procedures. The washed cells were resuspended in 5 ml of buffer containing 1X broad
range protease inhibitor (ROCHE) and cells were homogenized by 10 strokes in a 15 ml
disposable tissue grinder system (VWR). The cell homogenate was centrifuged at 2000 X g for
2 minutes to remove debris and then at 4000 X g to pellet a combination of nuclei and cell
membranes. The supernatant was collected and transferred to Beckman 3.9 ml Quick-Seal
centrifuge tubes which were sealed and centrifuged at 100 000 X g for 2 min in a Beckman
TLN100 rotor to pellet the mitochondria, endosome and lysosomes, all organelles associated
with RUBV CPVs. The resulting pellet (P100) was resuspended in 0.75 ml RIPA buffer (10 mM
Tris-HCl pH 7.4, 150 mM NaCl, 3 mM EDTA, 1% Triton X-100, 0.1% SDS, and 0.5% DOC)
containing 1X broad range protease inhibitor (ROCHE) at 40C to solubilize the CPVs along with
associated proteins from the pellet fraction. After centrifugation at 13,000 rpm for 5 minutes
(Eppendorf tabletop centrifuge), the solubilized fractions were immunoprecipitated with antiFLAG monoclonal antibody-conjugated agarose beads (SIGMA) for 4 to 6 hours at 4oC. The
precipitate was then washed 5 times with RIPA wash buffer (10 mM Tris-HCl pH 7.4, 150 mM
NaCl, 0.5% Triton X-100, 0.5% DOC, and 3 mM EDTA). Bound proteins were eluted by
addition of 2X SDS-PAGE loading buffer (100 mM Tris-HCl pH6.8, 20 mM dithiothreitol, 4%
SDS, 0.2% bromophenol blue, and 20% glycerol) and boiling. Eluted proteins were resolved on
6% and 10% SDS-PAGE gels, stained with GelCode Blue (Pierce) and scanned with a Typhoon
imager (GE Healthcare) using no filter and an excitation wavelength of 633nm. Lanes containing
proteins isolated from Robo502 and Robo502-912 infected cell pulldown samples were
compared. Protein bands were excised from the gel using a clean scalpel and sent to the Scripps
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Center for Mass Spectrometry, California. Excised protein bands were sent in deionized water, in
1.5 ml eppendorf tubes. Protein identification was performed by the center using nanoLC/MS/MS.
Western blot analysis
Proteins were separated by SDS-PAGE and then electorphoretically transferred to
nitrocellulose membranes (Whatman) with a mini Protean II apparatus (Biorad) using 1X
transfer buffer (25 mM Tris pH 7.5, 0.192 M glycine, 20% methanol) at 100V for 1 hour. The
membrane was blocked overnight with 5% dried milk in TBS (20 mM Tris-HCl, pH 7.5, 175
mM NaCl) and the blot was probed with mouse anti-FLAG monoclonal antibody (Sigma), goat
anti-VPS16 polyclonal antibody (IMGENEX), rabbit GU-8 anti-RUBV P90 antibody [17] or
rabbit anti-Lamp2 polyclonal antibody (Abcam), each diluted 1:1000 in antibody dilution buffer
(1% non-fat milk powder, 0.02% sodium nitrate in TBS buffer [20 mM Tris-HCl, pH 7.5 and
175 mM NaCl]). The proteins were detected using a BCIP/NBT (Roche) colorimetric assay with
alkaline phosphatase-conjugated anti-mouse, anti-goat or anti-rabbit alkaline phosphatase
conjugated secondary antibody (Promega) (1:5000 dilution).
Electron microscopy of the P100 pellet to detect the presence of CPVs
The P100 pellet fraction from uninfected or Robo502-912-infected Vero cells was fixed
in 4% glutharaldehyde-PBS, and sent in an eppendorf tube to Dr. Cristina Risco, Center for
Biotechnology, Universidad Autonoma, Cantoblanco Campus, Madrid, Spain, for analysis by
transmission EM.
Immunofluorescence assay of P100 pellet with dsRNA antibody
Confirmation of the presence of dsRNA in the CPV-concentrated fraction (P100 pellet
fraction) (as an indication of the presence of active replication complexes) was done using

33
antibodies specific for dsRNA in an immunofluorescence assay (IFA). A small amount of the
P100 pellet fraction from uninfected or infected cells was smeared onto an 18mm glass coverslip
followed by fixation with 4% paraformaldehyde in PBS for 30 min at 4oC. The coverslips were
washed with PBS and incubated PBS-0.25% saponin for 10 min at room temperature to
permeabilize the membrane bound CPVs. Coverslips were washed again with PBS and blocked
with PBS, 2% BSA, 0.25% saponin for 30 min at room temperature. Primary antibody to
dsRNA, a monoclonal mouse anti-dsRNA antibody (J2 from Biocenter, Szeged Hungary), was
diluted in PBS, 0.1% BSA and 0.25% saponin (1:500 dilution) and added to the coverslips for 1
hour. After three washes in PBS, secondary mouse anti-FITC antibody (SIGMA) diluted in PBS,
0.1% BSA, 0.25% saponin (1:1000) was added followed by incubation for 30 minutes at room
temperature. The coverslips were washed with PBS, inverted and mounted onto glass slides with
ProLong gold anti-fade reagent (Molecular Probes/Invitrogen). The cells were visualized with a
Zeiss Axioplan 2 microscope with epifluorscence capacity using the 20 X objective.
Results
Identification of host proteins co-immunoprecipitating with P150 by 2D gel electrophoresis
The initial strategy employed to identify host cell proteins interacting with the RUBV
P150 nonstructural replicase protein was co-immunoprecipitation from cytoplasmic lysates of
RUBV-infected cells. Advantage was taken of the development of RUBV constructs with an
epitope tagged P150 that exhibit no difference in titer from corresponding constructs without the
tag [18]. The proteins encoded by the constructs used in this study are shown in Fig 2.1. Since
virus infection alters the infected cell, cells infected with the standard virus without the tag were
used as the control rather than uninfected cells. In this way, any host proteins that cross react
with the antibody used in immunoprecipitation and are released or relocalized by virus infection
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will not be misidentified as proteins co-immunoprecipitating through an association with P150.
Infected cells were harvested 48 after infection because it was previously established that
maximal levels of P150 expression occur at this time point [17].
Fig. 2.2 describes the protocol used to identify host proteins co-immunoprecipitating with
P150 separated by two-dimensional gel electrophoresis (2-DE).

The primary limitation in

resolving proteins using 2-DE is that the proteins cannot be denatured prior to electrophoresis in
the first dimension since this separation is based on isoelectric focusing under high voltage. In
total,

co-immunoprecipitation

followed

by

isoelectric

focusing

and

separation

of

immunoprecipitated proteins according to molecular weight was conducted. The pair of gels
with the best resolution is shown in Fig. 2.3A. As can be seen, background (ie spots present in
both gels) was high. However, the Image Master Platinum 2.0 program that was used to compare
protein spots present on “control” and “sample” gels was able to identify 17 protein spots
specifically immunoprecipitated by anti-FLAG antibody from Robo502-912-infected cells.
Although these spots are all marked in the gels shown in Fig. 2.3A, blow ups of regions
containing the spots specific to the Robo502-912 gel are shown in Figures 2.3B through 2.3G.
These unique spots were picked and analyzed by trypsin digestion and mass spectrometry. Each
protein spot analyzed by mass spectrometry contained more than one possible “hit” or protein
prediction. Only proteins that had a score more than 10 were considered valid and the most
probable protein hit for each spot is listed in Table 2.1. As can be seen, 13 out of 17 hits had low
scores, ie. ~10. Many of these spots had a number of possible hits for protein identities with
slightly lower scores than the one listed. The low scores for protein identity hits from these spots
could be due to more than one protein in a spot or low abundance of the protein in the spot. In
this regard, it should be noted that some of the unique spots were very close to larger spots
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present in both the control and experimental gels (e.g. spots 258, 291, 471, 472, and 477; Fig.
2.3A). Out of the 17 protein IDs however, 4 had scores that ranged from 16 through 58 and were
considered possible P150 interacting candidates.
Of the four spots that yielded identity hits with scores >10 (spot 97, vacuolar protein
sorting protein 16 with a score of 16.09; spot 59, zinc finger protein 43 with a score of 18.06;
spot 85, B cell lymphoma CLL/lymphoma 11A isoform with a score of 18.08; and spot 62,
follistatin-like 5 with score of 58) vacuolar protein sorting protein 16 (Vps16, spot 97) was
chosen as a candidate protein to test further for association with P150 because its function was
consistent with formation of vesicles by the RUBV replication in association with lysosomes and
antibody to this protein was commercially available. Vps16 has been characterized as one of the
class C Vps genes involved in multiple vesicle transport pathways, particularly involving the
biogenesis and stability of lysosomal vesicles. It also serves as the delivery pathway for
lysosomal proteins [19, 20]. In the Western blot used to confirm the binding of Vps16 to FLAGtagged P150, the anti-Vps16 antibody was capable of detecting the protein in cell lysates
(indicated by arrow in the Western blot of Fig. 2.4). However, when P150 was
immunoprecipitated

from

lysates

of

Robo502

or

Robo502-912-infected

cells,

co-

immunoprecipitation of Vps16 with FLAG-tagged P150 did not seem to occur (lane 2, Fig. 2.4).
There were two protein bands detected in lanes 1 and 2 at a higher molecular weight than the
positive control band in lane 3. We do not know what protein these bands represented.
Overall, the strategy of co-immunoprecipitation and 2-DE to detect host proteins
interacting with P150 was too cumbersome, not routinely reproducible, and plagued by high
background and therefore another approach was chosen to identify proteins associating with
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P150, namely concentrating the CPVs in which RNA synthesis occurs prior to coimmunoprecipitation.
Identification of host proteins co-immunoprecipitating with P150 following concentration of
CPVs by 1D gel electrophoresis
Fig. 2.5 shows a schematic of the new approach that was used to concentrate CPVs prior
to co-immunoprecipiation with FLAG-tagged P150.

This approach was adapted from a

published protocol used to isolate fractions containing lysosomes and endosomes as well as
mitochondria and was shown to work successfully with different types of cell lines [14].
Basically, the protocol involved cell lysis by Dounce homogenization followed by two low speed
centrifugations and then a high speed centrifugation. Lysosomes, endosomes and mitochondria
remain in the supernatant following the two low speed centrifugations (S1 and S2) and
concentrate in the final pellet following the high speed centrifugation (P3). As shown in Figures
2.6 and 2.7, FLAG-tagged P150 in Robo502-912 infected cells was present in equal amounts in
the supernatant and pellet following the first centrifugation that cleared unlysed cells and other
debris, but subsequently the majority distributed into the post-nuclear supernatant (S2) following
the second low speed centrifugation and the pellet (P3) following the high speed centrifugation,
as expected. No P150 could be detected by the anti-FLAG antibody in any fractions from cells
infected with Robo502, which expresses an untagged P150.
To confirm that the P3 fraction contained lysosomes, a Western blot was probed with
antibodies against Lamp2 protein, a lysosomal membrane associated glycoprotein that is used as
a lyosomal marker. Results shown in Fig. 2.8 confirmed the presence of Lamp2 in the P3
fraction, but not the S3 fraction. This is pertinent to our goal of isolating RUB P150 associated
with replication complexes because RUBV forms replication complexes in vesicles associated
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with lysosomes [21]. However, the amount of Lamp2 protein in the Robo502 P3 fraction was
lower that the amount in the Robo-502-912 P3 fraction, and is most probably a result of unequal
amounts of protein samples being loaded during this one experiment. To further show that
replication complexes were isolated using the fractionation protocol, the P3 fraction was fixed
and analyzed by electron microscopy (Fig. 2.9) and an immunofluorescence assay (IFA) (Fig.
2.10) to detect dsRNA, a marker of RNA-dependent-RNA synthesis. As shown in Figures 2.9 A,
B and C, structures similar to CPVs seen in RUBV-infected cells (Fig. 2.9D) were detected in
the P3 fraction from Robo502-912-infected cells, but not in the corresponding P3 fraction from
control uninfected cells (Fig. 2.9E). When fixed smears of P3 fractions were probed with an
antibody to double stranded RNA (dsRNA), the fraction from Robo-502-912-infected cells
contained multiple distinct bright spots not seen in the fraction from control uninfected cells
suggesting the presence of dsRNA in the infected samples (Fig. 2.10). Taken together, these data
demonstrate that viral replication complexes were present in the P3 fraction.
The P3 fraction from Robo502 and Robo502-912-infected cells was next used for
experiments to detect interactions of host cellular factors with P150 by co-immunoprecipitation
following the approach diagrammed in Fig. 2.11. First, the P3 fraction was solubilized with
various lysis buffers to maximize the recovery of P150 as shown in Fig. 2.12. Maximal recovery
was obtained using the RIPA buffer that had been used to produce whole cells lysates in the 2DE analysis. Maximum recovery was desired to increase the chances of being able to detect the
presence of host cellular proteins that may reside in the RC. However, to ascertain that the
process yielding maximum recovery did not affect the binding of RUBV P150 with other
proteins, the interaction of a the viral P90 which is known to bind P150 was tested. RUBV P90,
the functional replicase protein [22], should be present in the replication complex [17] and
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therefore should be present in the same fraction as RUBV P150. Fig. 2.13A (lane 4) and Fig.
2.13B (lanes 9 and 10) show that P150 and P90, respectively, were present in the same fraction
(supernatant fraction) of RIPA buffer solubilized P3 fraction. As shown in Fig. 2.13B, P90 was
detected in solubilized P3 fraction of both Robo502 and Robo502-912-infected cells. P90 was
detected in both because the Western blot was probed with GU8, a rabbit polyclonal antisera
against bacterially expressed RUBV P90. To determine whether the extraction method perturbed
the physical interaction of RUB P150 with RUB P90, immunoprecipitation was done with antiFLAG antibody followed by Western analysis to detect the presence of both P150 and P90 using
mouse anti-FLAG and rabbit anti-GU8 antibodies, respectively (Fig. 2.14 A and 2.14 B,
respectively). Lane 2 of Figure 2.14A shows that P150 was successfully immunoprecipitated
from the solubilized supernatant of the P3 fraction, while Lane 4 of Fig. 2.14B shows that P90
was co-precipitated with P150. This experiment demonstrated that the interaction of RUBV P150
with a known interacting protein, i.e. RUB P90, was preserved during the preparation of the
CPV-containing fraction and subsequent extraction of P150 from the fraction. Therefore it could
be postulated that the interactions of other binding partners of P150 would be similarly
preserved.
Next, we wanted to see if host cell proteins were immunoprecipitated with RUBV P150
from the CPV fraction. Fig. 2.15 shows SDS-PAGE separation of the proteins that were
immunoprecipitated by anti-FLAG antibody from the solubilized P3 fraction from Robo502
(Lane 1) and Robo502-912 (Lane 2) infected cells. As can be seen, the subcellular fractionation
and concentration of CPVs substantially reduced the background encountered when
immunoprecipitation was done from unfractionated cell lysates (Fig. 2.3). Two protein bands
were detected in the Robo502-912 lane that was not present in the Robo502 control lane. One of
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these protein bands (CPV1) migrated between the 116 kDa and 202 kDa MW markers while the
second (CPV2) migrated slightly more rapidly than did the 98 kDa MW marker. Trypsinization
and mass spectrometry nano-LC/MS/MS analysis of CPV1 and CPV2 identified both proteins as
the RUBV P90 replicase protein with 95% confidence (Table 2.2). While the Mr of the CPV2
band corresponded with the molecular weight of P90, the Mr of CPV1 did not and was indicative
of P150. However, a western blot of an 18x16 cm SDS-PAGE gel similar to the one used to
resolve proteins for mass spectrometry analysis probed with mouse anti-FLAG antibody to
identify the location of FLAG-tagged P150 showed that the Mr of P150 was very similar, but
possibly slightly less, than that of CPV1 (Fig. 2.16). We concluded that CPV1 most likely was a
dimer of P90 which would have a Mr of 180 kDa (Fig. 2.16 B, indicated in asterisk).
Nevertheless, P90 was the only pairing partner of P150 that was identified with the technique
and protein staining reagent that we used for this particular experiment. No other proteins with
molecular mass lower that 90 kDa, were found to interact with P150 (data not shown).
Discussion
The goal of this study was to identify host cell proteins that interact with RUBV proteins
and play an important role in viral replication. Previous studies on the interactions of host
factors with RUBV components identified cellular proteins that bind to the 5’ and 3’ untranslated
regions (UTR’s) of the RUBV genomic RNA and to the P90 replicase protein and the C protein.
Specifically, La autoantigen bound to the 5’ UTR [23] and calreticulin bound to the 3’ UTR [24].
These associations were discovered by introducing radiolabeled RNA probes into cell lysates
and detecting binding in gel mobility shift assays. Binding of the retinoblastoma protein to P90
was found based on bioinformatics predictions of binding motifs for this protein in the P90
protein while binding of citron kinase to P90 was identified through yeast two-hybrid assays [25,
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26]. Finally, binding of mitochondrial p32 to the C protein was discovered using a yeast twohybrid assay and the binding of polyA binding protein to C protein was discovered by using a
GST-capsid fusion protein expressed in mammalian cells and affinity purification of capsidbinding partners (in the transfected cells) on gluthathione agarose beads [27, 28]. Despite
follow-up studies, the role that any of these proteins plays in RUBV replication has not been
determined. We reasoned that a more promising way of isolating cell proteins directly involved
in RUBV replication would be by co-immunoprecipitation with the RUBV replicase from lysates
of infected cells in which virus replication was ongoing. We took advantage of the recent
successful insertion of an epitope tag into one of the RUBV replicase proteins, P150, without
compromising viral RNA infectivity and used a virus expressing a FLAG-tagged P150 in this
study. Similar approaches have been taken with other viruses, e.g. the alphavirus Sindbis virus,
albeit with a GFP tag [29, 30].
The first approach taken in this Specific Aim was to resolve proteins coimmunoprecipitating with P150 from cytoplasmic lysates of RUBV-infected cells by twodimensional electrophoresis (2-DE), a method which first resolved proteins first by iso-electric
focusing (charge) and then by molecular mass. The primary advantage conferred by this method
is a better separation of proteins compared to the traditional one dimensional SDS-PAGE. 2-DE
also allows the identification of post-translational modifications such as phosphorylation and
glycosylation on a single species of protein. 2-DE was first introduced by P.H. O’Farrel and J.
Klose in 1975 [31, 32]. A modification of this original method by Angelika Gorg [33] provided
an easier way to separate proteins on the first iso-electric dimension and, as a result, more
consistent patterns of proteins were seen. The traditional method relied on a mixture of carrier
ampholytes to facilitate the iso-electric focusing of proteins that led to long focusing times and
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modifications of pH gradients that caused non-reproducible results. Commercial immobilized pH
gradients (IPG) with the modifications of Angelika Gorg overcame some of the limitations posed
by the traditional method of iso-electric focusing. Nevertheless, many steps are necessary to
prepare the immunoprecipitated samples properly to retain the native conformation for
successful resolution in the first dimension. The majority of research that utilizes this method
involves detecting differential expression of proteins in cells, for example tumor versus nontumor cells or infected versus non-infected cells. However, 2-DE has been used as a tool to
study protein-protein interactions as well. For example, two studies, from which we derived our
approach, were from labs that studied the interactions of host cellular factors with the HCV
NS5A replicase and core protein [16, 34].
As a control for detecting non-specific co-immunoprecipitation by the FLAGmonoclonal antibody-conjugated agarose beads from lysates of Robo502-912-infected cells,
lysates were used of cells infected with Robo502, which lacked a FLAG epitope. A non-epitope
tagged virus was used as a control for changes in intracellular expression and redistribution of
cellular factors that may occur as a result of infection. Most researchers doing similar studies
have used lysates from uninfected cells as a control [35, 36] and have failed to take into account
the changes in cells caused during infection. As a result, these studies yield higher levels of false
positives
The 2-DE gels yielded a large number of background spots; however, comparison of
proteins immunoprecipitated from lysates with non-tagged and tagged P150 led to the
identification of seventeen unique protein spots that were present in the latter. These spots were
visible by staining with deep purple (GE-Amerham), a fluorescent stain that detects proteins at
concentrations as low as 50 pg. Even though staining by this method increases sensitivity (low
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detection limits), it increases background and as a result, produces false positives. The seventeen
spots were picked and analyzed though trypsin digestion and MALDI-TOF analysis. However,
the end result for most (thirteen) of the spots was more than twenty proteins as a possible
identity for each spot with relatively low scores for each, suggesting that the concentration of
the proteins in the spot were low and/or contaminated by proteins in nearby background spots.
There are several possible reasons for this finding. Firstly, the many steps that were involved
before the proteins in the sample could be focused on the first dimension could have led to the
loss of important binding proteins. Secondly, the decrease in the amount of real binding proteins
led to masking by proteins that were initially present as non-specific proteins. Finally, the high
sensitivity of the staining method gave an illusion of abundance when actually low levels of real
binding proteins existed to begin with. To add to these factors, when the proteins are processed
through trypsin digestion and further repetitious steps for peptide purification using ZipTip
(Millipore), the amount of peptides available for identification become even less.
Despite the low confidence in the proteins identified from thirteen of the seventeen spots,
the top candidates from the remaining spots had higher scores. Some of the proteins with higher
scores were vacuolar protein sorting protein 16 (Vps16) with a score of 16.09, zinc finger protein
43 with a score of 18.06, B cell lymphoma CLL/lymphoma 11A isoform with a score of 18.08
and follistatin-like 5 with score of 58.10. Other than Vps16, not much has been reported in the
literature about the functions of the other identified proteins, nor were there any reagents readily
available to test their binding to P150. Thus, Vps16 was chosen for further analysis because it
functions in protein transport between the Golgi and vacuolar organelles (e.g., endosomes, the
sites of RUBV RC assembly) and an antibody was available. However, we were unable to
obtain data indicating that Vps16 interacted with P150 by co-immunoprecipitation.
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The high background encountered following co-immunoprecipitation from lysates of
infected cells along with the problems encountered with 2-DE (amount of effort, lack of
reproducibility, and unconvincing protein identities from unique spots) led us to choose another
approach to detect proteins interacting with P150, namely a fractionation protocol designed to
concentrate endosomes and lysosomes, the precursors of RUBV CPVs that house the RCs. Such
a procedure should reduce background which would allow us to use 1-D SDS-PAGE to resolve
proteins co-immunoprecipitating with P150 (the method most commonly employed currently in
similar studies on other viruses [29, 30]). Additionally, one of the limitations posed by 2-DE
method is the under-representation of membrane proteins due to poor solubility and aggregation
which makes it difficult for these proteins to enter the second dimension from the IEF strip [33,
37]. This is a significant problem as far as our research is concerned simply because P150 is a
membrane-associated protein (unpublished data) and viral RNA replication in RUBV infected
cells occurs in association with membranes [2, 38]. Thus, immunoprecipitation of P150 from a
CPV-enriched fraction followed by SDS-PAGE, rather than 2-DE, increased the chances of
identifying membrane proteins associated with P150. Furthermore, recent studies have shown
that only a fraction of SINV non-structural proteins are present in CPVs and the rest are present
in the cytoplasmic locations other that the modified lysosomes [6]. Similarly RUBV P150, it has
been shown to exist both as punctuate foci in the cytoplasm of infected cells, which likely
correspond to CPVs, and in fibrous structures, particularly late in infection when we made our
lysates [7]. These different intracellular locations of P150 suggest that the protein is involved in
different stages of virus replication at different times post-infection. Therefore our approach of
isolating CPVs prior to studying host factors interacting with P150 in the replication complex
was more likely to yield information on host factors that participate in virus RNA synthesis.

44
As discussed in Chapter 1, co-immunoprecipitation was used to identify cell proteins that
interacted with two of the nonstructural replicase proteins of the alphavirus, SINV, namely nsP2
and nsP3, both of which were successfully tagged with GFP without compromising virus
infectivity. While a plethora of cell proteins were identified as interacting with nsP2 and nsP3,
including cytoskeleton proteins, chaperones, elongation factor 1A, heterogeneous nuclear
ribonucleoproteins, 14-3-3 proteins, and some of the ribosomal proteins [29, 35, 39], emphasis
was placed on G3BP1 and G3BP2 and the the mosquito cell homolog, Rasputin [29, 30]. The
association of these proteins with both nuclear pores and stress granules led to the hypothesis
that recruitment of these proteins by the SINV nonstructural proteins played a role in shutoff of
nuclear transcription and/or reformatting the translational capacity of the cell to favor translation
of virus proteins. Overall, these co-immunoprecipitation studies emphasized the complexity of
the interaction between virus and cell proteins. However, a definitive role was not established for
any of these proteins in virus replication. More convincing was the cell fractionation study that
identified hnRNP-K, along with stress response and cytoskeletal proteins, as a protein enriched
in membrane fractions harboring active SINV RCs [36]. It was subsequently shown that hnRNP
K co-immunoprecipitated with the SINV nonstructural proteins and the subgenomic (but not the
genomic) RNA and it was hypothesized that it played a role as part of the RC in regulating the
ratio of genomic and subgenomic RNA synthesis and subsequent subgenomic RNA translation.
The architecture of alphavirus CPVs was described as early as 1968 [40, 41] and
subsequent literature added to the description, primarily using electron microscopy and immunoelectron microscopy [5, 42]. Active alphavirus RCs form in membrane limiting regions of
modified vacuoles and were termed CPV-I. These vacuoles were later shown to be derived from
lysosomes. Since lysosomes evolve from endosomes, it was thought that initial formation of RCs
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within endosomes resulted from virus entering the cell through receptor mediated endocytosis.
However, this idea did not hold water because the multiplicity of infection did not correspond
with the number of CPVs that were formed [42]. Additionally, CPVs are formed following
transfection of virus RNA, indicating that their formation was a post-translational event not
dependent upon initial localization of virions to an endosome or lysosome.

CPVs are

approximately 0.6-2.0 µm in diameter and the actual sites of RNA synthesis are membranebound spherules 50 nm in diameter that line the inner surface of the CPV vacuole at regular
intervals. As for RUBV, CPVs resembling those produced by alphaviruses have been visualized
in cells following both transfection and infection [2, 3]. The CPVs are derived from lysosomes
and the spherules contain dsRNA and both the P150 and P90 replicase proteins. In order to
isolate these CPVs, we took advantage of a previously established differential centrifugation
method for fractionation of endosomes, lysosomes and mitochondria from a variety of eukaryotic
cell lines [14].
When this fractionation method was applied to a post-nuclear supernatant, P150
segregated quantitatively into the subsequent P3 or “P100” pellet fraction expected to be
enriched for endosomes, lysosomes, and mitochondria. In confirmation, we showed that this
fraction contained the Lamp2 protein, which is a marker for lysosomes. We next sought physical
evidence of the presence of CPVs through electron microscopy and indeed the P100 fraction
contained vacuolar structures comparable to previously published electron micrograph images
of RUBV CPV that were not present in the corresponding P100 fraction from uninfected cells
[3]. The presence of replication complexes in the P100 fraction was supported by a novel
experiment whereby the P100 fractions of both control as well as infected Vero cells were fixed
and stained with antibodies to double stranded RNA; bright green spots in P100 fractions from
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infected cells and not from the control cells were observed. Based on all these observations, we
concluded that the P100 fraction contained active replication complexes.
The next challenge was to extract P150 from the membranous CPV while maintaining
important binding partners. The P100 fraction was solubilized using three different lysis buffers
to maximize the extraction of P150. Co-immunoprecipitation of P90 was evaluated as a positive
control and also to ensure that the solubilization technique did not disrupt the potential binding
partners of P150. Standard RIPA buffer containing both 1% Triton X-100 and 0.5% DOC was
the most successful in extracting P150 from the membranous complex. This finding was in
agreement with a previously published paper on the successful recovery of functional replication
complexes from alphavirus infected cells [43]. In this paper, RIPA buffer in the presence of 1%
Triton X-100 and 1% DOC was successfully used to extract replication complexes from a P15
fraction of alphavirus infected cells yielding all of the nonstructural proteins nsP1, nsP2, nsP3,
nsP4 and some nsP34, and an unidentified protein (~120 kDa) believed to be a host cellular
protein.
In our study, after confirming that the solubilized P100 fraction contained both P150 and
P90 and that P90 co-immunoprecipitated with P150, we proceeded to use 1-D SDS-PAGE to
resolve putative cell proteins co-immunoprecipitating with P150 for subsequent identification by
mass-spec analysis.

SDS-PAGE analysis of proteins immunoprecipitated by anti-FLAG

antibody revealed that cell fractionation substantially reduced the background present following
similar immunoprecipitation from unfractionated, cytoplasmic lysates. Two protein bands were
found to be immunoprecipitated by anti-FLAG antibody specific for Robo502-912. These two
proteins were identified as RUBV P90. While the molecular mass of CPV2 fit that of P90, the
identification of CPV1 as P90 was not expected. Further analysis of the protein band in the
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CPV1 region, led us to identify an additional band above the one where the presence of P150
was confirmed through Western blot analysis. P150 may not have been identified through massspectrometry because the protein band that was excised for analysis may have contained the
protein from the higher molecular mass. We hypothesized that the CPV1 protein band that was
identified could be a P90 dimer. The high confidence level (95%) of a number of peptides that
matched P90 and the molecular mass of the protein, support our hypothesis. However, further
analysis needs to be done to confirm this hypothesis.
However, these data do not mean that host proteins are not involved in the replication of
virus genome. Host cellular factors have been shown to interact, as described earlier, with the 5’
UTR and 3’ UTR of a virus genome. Specific template recognition by a virus RdRp is important
to ensure that replication occurs properly. Some of the factors that are important in this respect
are the sequences and secondary structures present at the 5’ end and the 3’end of the genome.
Binding of host cell proteins to these RNA sequences/structures and to the RDRP itself could
function to direct the RdRp to the template to promote template specifity as well as to form an
active replication complex [1, 44, 45]. In the classic example of the replicase of bacteriophage
Qβ, the binding of host cellular elongation factors EF-Tu, EF-Ts and ribosomal protein S1 to the
Qβ replicase is important for the formation of the holoenzyme and synthesis of plus strand RNA
from negative strand template [46]. The binding of another host factor, HF1, a ribosomal protein
to the 3’ end of this RNA genome is required for negative strand RNA synthesis [47]. An
analysis of RCs formed by flock house virus (FHV), a nodavirus that included electron
tomography, it was concluded that in the 50 nm spherules formed on the outer mitochondria
membranes that comprise the RC that there was little or no room for any other factors other than
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viral replicase protein and the virus RNA [48]. The 50 nm spherules that was studied in FHV are
similar to the ones found to line the interior of CPVs in RUBV infected cells.
While we found no host cell proteins interacting with P150 in the replication complex, it
has to be pointed out that there were caveats to the approach and method that we used to isolate
proteins from the RUBV infected cells. Firstly, even though the fractionation procedure reduced
the amount of background for the immunoprecipitation experiment specific for Rob0502-912, it
also reduced the amount of host proteins that may already have been low in abundance to begin
with. As a result, the enrichment of viral proteins led us to detect P150 and P90 that were higher
in abundance in that fraction, and not low abundance host proteins that were faintly detected
using by GelCode Blue staining reagent. The second caveat to our method was the fractionation
procedure itself. The high speed of the final fractionation step that led to the formation of the P3
pellet may have perturbed host-virus protein interactions. Finally, the solubilization technique
using denaturing detergents such as DOC and SDS to remove P150 from the P3 fraction may
have disrupted important host-virus protein interactions as well. For future studies, analysis of
the all the proteins enriched in the P3 fraction of RUBV infected cells could be done in
comparison to a P3 fraction from uninfected cells. The entire set of proteins in a P3 fraction can
now be analyzed by high performance liquid chromatography followed by peptide identification
through tandem mass spectrometry.
In conclusion for this aim, we did not find P150 binding to host cellular proteins in the
context of CPVs. As will be seen from the data obtained for the second Specific Aim, P150 does
bind to host cellular factors. However this interaction most probably does not occur in the
context of P150 within the RC. P150 is located in different places and structures in the
cytoplasm of the infected cells where it may have different functions. In its role as a virus
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replicase, P150 does not seem to form stable interactions that can be detected with the techniques
used. The interaction of host cellular factors with P150 in its non-CPV form is further
investigated in the next Specific Aim.
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Figure 2.1. Genomic diagram of Robo502-912.
Robo502-912, the experimental virus used in this study, contains a FLAG epitope
inserted in a Not I site (nt 1684 and 1685) in the nonstructural replicase protein P150
gene allowing detection of P150 produced by this virus by commercially available
FLAG reagents. Insertion of the FLAG epitope tag did not affect the efficiency virus
replication and virus titers obtained from this construct was comparable to those
produced from the wild type Robo502 virus parent. The Robo502-912 construct was
developed by Dr. Wen-Pin Tzeng [9].
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Figure 2.2. Schematic showing the procedures used to identify host cell proteins binding to
RUBV P150.
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Robo502

Robo502-912

Figure 2.3A. Two-dimensional gel electrophoresis analysis of proteins immunoprecipitating
with RUBV P150.
Robo502-912- (FLAG-tagged P150) and Robo502-infected cell lysates were
immunoprecipitated using anti-FLAG antibody-conjugated agarose beads and resolved by 2DE analysis. Proteins were focused on 13 cm Immobiline strips (pH 3-10 non linear range)
for the first dimension separation (horizontal), followed by second dimension separation
(vertical) by 10% SDS-PAGE. The gel on the left is the control sample (Robo502 infected
cells) while the one on the right is the experimental sample (Robo 502-912 infected cells).
The gels were stained with deep purple fluorescence stain (GE-Amersham) and viewed with a
typhoon imager (GE-Amersham). A total of 17 protein spots were identified using
ImageMaster Platinum software (GE-Amersham). Protein spots unique to Robo502-912
infected cells are enclosed within white boxes and the corresponding numbers were assigned
by the software. Blow ups of regions of the gel containing unique spots are shown in Figs.
2.3B through 2.3G.
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Figure 2.3B. Close-up of 2-DE gel shown in Figure 2.3A.
Protein spots unique to Robo502-912 infected cells are enclosed within
circles.

Figure 2.3C. Close-up of 2-DE gel shown in Figure 2.3A.
Protein spots unique to Robo502-912 infected cells are enclosed within circles.
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Figure 2.3D. Close-up of 2-DE gel shown in Figure 2.3A.
Protein spots unique to Robo502-912 infected cells are enclosed within
circles.

Figure 2.3E. Close-up of 2-DE gel shown in Figure 2.3A.
Protein spots unique to Robo502-912 infected cells are enclosed within circles.
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Figure 2.3F. Close-up of 2-DE gel shown in Figure 2.3A.
Protein spots unique to Robo502-912 infected cells are enclosed within circles.

Figure 2.3G. Close-up of 2-DE gel shown in Figure 2.3A.
Protein spots unique to Robo502-912 infected cells are enclosed within circles.
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Table 2.1. Mass-spectrometry identification of spots picked from a 2D gel (Fig. 2.3A)
Proteins shown were identified as the top candidates for each of the spots.
*VPS16 was chosen as a candidate protein to confirm interaction and test confidence levels
of mass-spectrometry data.
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Robo502912

Robo502

Lysate

Vps16

1

2

3

Figure 2.4. Lack of co-immunoprecipitation of Vps16 with P150 antibody.
To test for association between Vps16 and P150, post nuclear fractions of Vero cells
infected with Robo502 (lane 1, negative control) or Robo502-912 (lane 2, experimental
sample) were immunoprecipitated with anti-FLAG antibody followed by SDS-PAGE and
Western blot probed with anti-Vps16 antibody. Lane 3 contains uninfected Vero cell
lysate to detect the presence of Vps16 protein. The absence of Vps16 in lane 2 indicates
that FLAG tagged P150 does not specifically interact with this cell protein. The asterisks
represent unknown protein bands that were immunoprecipitated by Robo502 and
Robo502-912 (lanes 1 and 2). There appears to be a very faint protein band at the same
location in lane 3 as well. This background protein band could have been enriched in the
immunoprecipitated sample.
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Figure 2.5. Schematic showing the procedures used to fractionate cell lysates to produce a
fraction enriched for membranous organelles such as endosomes, lysosomes, and mitochondria
plus, putatively, RUBV-induced CPVs.
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Figure 2.6. P150 distribution in subcellular fractions.
Lysates of Robo502-912 and Robo502-infected Vero cells were fractionated following
the procedure outlined in Fig. 2.5. A 1% aliquot (percentage value based on starting
material) of each fraction (pellets were solubilized in SDS-PAGE sample buffer) was
resolved by 6% SDS-PAGE gel followed by Western blotting probed with mouse antiFLAG antibody.

Figure 2.7. P150 distribution in high-speed centrifugation fractions.
After the final high speed centrifugation in the fractionation procedure outlined in Fig.
2.5 for lysates of Robo502- and Robo502-912-infected Vero cells, proteins in the
supernatant fraction were concentrated by acetone precipitation and resolubilized in
SDS-PAGE sample buffer. The P3 pellet was also solubilized in the same amount of
SDS-PAGE sample buffer. Equal aliquots were then resolved by 6% SDS-PAGE
followed by Western blotting probed with mouse anti-FLAG antibody.
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Figure 2.8. Presence of Lamp2 lysosomal marker in high-speed centrifugation fractions.
After the final high speed centrifugation in the fractionation procedure outlined in Fig. 2.5
using lysates of Robo502- and Robo502-912-infected Vero cells, the supernatant fraction
was concentrated by acetone precipitation and resolubilized in SDS-PAGE sample buffer.
The P3 pellet was also solubilized in the same amount of SDS-PAGE sample buffer. Equal
aliquots were then resolved by 6% SDS-PAGE followed by Western blotting probed with
rabbit anti-Lamp2 polyclonal antibody. The amount of Lamp2 P3 fraction of Robo502
appears less than amounts present in P3 fraction of Robo502-912. This is most probably a
result of unequal amounts of protein samples present in each aliquot during this one
experiment.

Figure 2.9. Electron micrographs of subcellular structures present in the P3 pellet fraction.
Following the fractionation procedure shown in Fig. 2.5, the P3 pellet fractions from
uninfected and Robo502-912 infected Vero cells were fixed with 4% glutharaldehye in PBS
and sent for transmission EM analysis to Dr Cristina Risco (Centro Nacional de
Biotecnologia, Madrid, Spain). Panels A, B and C show micrographs from Robo502-912infected cells while Panel E shows a micrograph from uninfected cells. CPVs in the
infected cells are indicated by arrows. As a comparison, an electron micrograph showing
the presence of cytopathic vacuoles (CPV) in RUBV-infected cells is shown in Panel D [3].

63

Figure 2.10. Immunoflurescence assay to detect the presence of dsRNA in the P3 pellet
fraction.
Following the fractionation procedure outlined in Fig. 2.5, a small amount of the P3 pellet
fraction from uninfected (A) or Robo502-912-infected (B) Vero cells was smeared onto an 18
mm glass coverslip and fixed with paraformaldehyde. To detect dsRNA, a replicative
intermediate indicative of viral RNA replication, primary antibody to dsRNA, a monoclonal
mouse anti-dsRNA antibody, was added followed by secondary anti-mouse FITC labeled
antibody. The coverslips were mounted onto glass slides with ProLong gold anti-fade reagent
(Molecular Probes/Invitrogen) and visualized with a Zeiss Axioplan 2 microscope with
epifluorscence capacity using the 20 X objective.
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Figure 2.11. Schematic showing the procedure to optimize solubilization of the P3
fraction prior to immunoprecipitation of P150.
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Figure 2.12. Solubilization of the P3 pellet with different lysis buffers.
Following the procedure outlined in Fig. 2.11, the P3 pellet from Robo502-912-infected Vero
cells was solubilized with RIPA buffer (Lanes 1 and 4), RIPA buffer lacking SDS and DOC
(lane 2) or a buffer containing 2% CHAPS and 2% SB 3-10 (lane 3). After solubilization,
equal volumes of the solubilized supernatants were resolved by 6% SDS-PAGE followed by
Western blotting probing with mouse anti-FLAG antibody. As can be seen, RIPA buffer gave
the best yield.

Figure 2.13. Distribution of P150 and P90 following solubilization of P3 fraction with RIPA
buffer.
The P3 pellet fraction from uninfected Vero cells or Robo502- or Robo502-912-infected Vero
cells was solubilized with RIPA buffer and the resulting supernatants and pellets (see Fig.
2.11) were resolved by 6% SDS-PAGE followed by probing with mouse anti-FLAG antibody
(to detect P150, lanes 1-4) or rabbit polyclonal anti-P90 antibody (detects P90 synthesized by
either Robo502 or Robo502-912, lanes 5-10). As can be seen, both P150 and P90 were
efficiently liberated from the pellet by RIPA buffer.
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Figure 2.14. Co-immunoprecipitation of P150 and P90 following solubilization of the P3
pellet.
Following solubilization of the P3 fraction from Robo502- (lanes 1 and 3) or Robo502912- (lanes 2 and 4) infected cells with RIPA buffer (see Fig. 2.11), the supernatants were
immunoprecipitated with anti-FLAG antibody to pull-down FLAG-tagged P150. The
immunoprecipitated proteins were resolved by 6% SDS-PAGE followed by probing with
mouse anti-FLAG antibody (to detect FLAG-tagged P150, Panel A) or rabbit polyclonal
GU-8 antibodies (to detect P90, Panel B). As can be seen, P90 co-immunoprecipitated
with P150 following lysis of the P3 pellet with RIPA buffer.
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Figure 2.15. 1D SDS-PAGE of proteins immunoprecipitated with P150 in the P3 fraction of
RUBV-infected cells.
P3 pellet fractions from Robo502- and Robo502-912-infected Vero cells that had been
solubilized with RIPA buffer were immunoprecipitated using mouse anti-FLAG antibodyconjugated agarose beads and the immunoprecipitated proteins were resolved using 6%
SDS-PAGE on a 18 X 16 gel format. The gel was stained using GelCode blue and
visualized using a Typhoon imager without any filters. Two bands present in the Robo502912-infected cell lysate, but not in the Robo502-infected cell lysate, designated CPV1 and
CPV2, were excised from the gel and sent for identification by trypsin digestion and mass
spec.
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Table 2.2. Mass-spectrometry identification of proteins co-immunoprecipitated with P150
following cell fractionation to enrich for CPVs.
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Figure 2.16. Comparison of SDS-PAGE of P150 and CPV1.
To compare the Mr’s of P150 and the CPV1 protein band, proteins immunoprecipitated with antiFLAG antibody from P3 fractions prepared from Robo502- and Robo502-912-infected cells were
resolved by 6% SDS-PAGE using the 18 cm X 16 cm format. The area in the region expected to
contain P150 was excised and subjected to Western blotting probed with mouse anti-FLAG antibody
(Panel A). In comparison with the gel from which CPV1 was identified (Panel B), the presence of
two bands in the CPV1 region was evident. During the process of excising protein band for massspectrometry analysis, the lower band (representing P150) may have been excluded leaving the upper
band (possibly representing P90 dimer) to be excised instead and identified.
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CHAPTER 3
Specific aims 2 and 3: To investigate the importance of two SH3 binding domains within
the RUBV P150 nonstructural protein in the virus life cycle and identify cell proteins with
which they bind
Introduction
Proteins with SH3 domains often bind to ligands containing PxxP motifs in their amino
acid sequence [1]. SH3 domains are 50 to 70 amino acids in length and are usually present in
proteins in eukaryotic cells involved in signal transduction [2]. Similar SH3 structures have
been identified in bacteria [3, 4] and are thought to play a role in bacterial pathogenesis upon
infection of a eukaryotic host [5-7]. In addition to signal transduction, SH3 domains in
eukaryotes are thought to play a role in directing cell compartmentalization [8, 9]. This
hypothesis is based on the finding that SH3 domains are present in various cytoskeletal proteins.
SH3 domains are composed of five β-strands and a single turn of helix [10]. This
topology allows formation of two triple-stranded, anti-parallel β−sheets at right angles relative to
one another creating hydrophobic pockets that bind PxxP motifs. The mechanism of PxxP
binding to SH3 domains has been characterized [11-13]. PxxP motifs form a left handed helical
structure with three residues per turn known as polyproline type II (PPII) helix. The PPII helix
lacks intramolecular hydrogen bonds, allowing carbonyl groups to form intermolecular hydrogen
bonds with target proteins. There are three binding pockets within an SH3 domain. Two of these
bind the Px or xP element in the PxxP motif while the third binds to a flanking residue, usually
an arginine, that is either before (RxxPxxP) or after (PxxPxR) the PxxP consensus sequence. The
twofold pseudosymmetry of the PPII structure allows it to bind to target SH3 domains in two
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different orientations, ie in an N- to C-terminal orientation or vice versa. This allows flexibility
in binding to a protein with an SH3 domain and may also contribute to the same binding partners
having two different functions. Proline is also unique in comparison to other amino acids
because it possesses a five-member ring fused onto the nitrogen, making it a secondary amine.
This feature allows other proteins to bind to the carbon fused to nitrogen without having to make
contact with the rest of the side chain and as a result allows for specific, low affinity interactions
to occur [1]. All these features make P-X-X-P domains, and the proline rich region of proteins
that contain them, excellent candidates for specific yet weak binding by other proteins [1], a
necessity for proteins involved in signal transduction as a quick and readily reversible, yet
specific, response is required.
PxxP consensus sequences present in viral proteins have been shown to bind host
proteins with SH3 domains [13-17]. Examples of viral proteins with a PxxP consensus sequence
that have been found to interact with known cell protein SH3 domains are human
immunodeficiency virus (HIV) Nef protein, bovine leukemia virus (BLV) gp30 transmembrane
protein, influenza A NS1 protein and hepatitis C virus (HCV) NS5A protein. The interaction of
these viral proteins with host proteins containing SH3 domains has been shown to be important
for virus replication as well as pathogenicity [14-17]. RUBV has a proline rich region (PRR) in
its P150 non-structural replicase protein, stretching from amino acids 716 to 782 of the protein
(which contains 1301 aa in total) (Fig. 3.1). Of the eleven PxxP motifs found in this region, three
of the motifs fulfill the criteria for the class II binding ligand involving SH3 domains, i.e.
PxxPxR. Based on previous findings that proline rich domains of other viral proteins have the
ability to interact with host cellular factors that possess SH3 domains, with the result of
modulating cell signaling [13, 15, 16, 18] it would not be unexpected to find that the P150 PRR
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engages in similar interactions. The goal of this study was to investigate whether the putative
SH3 binding domains in the RUB P150 PRR are of significance in the virus replication cycle. If
so, it would be a novel finding in the Togaviridae family.
Materials and methods
Cells and virus
The 293-T line of transformed human embryonic kidney cells (HEK) (ATCC) was grown
and maintained at 37oC with 5% CO2, in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum (FBS) and penicillin-streptomycin (100 µg/ml). The
Vero line of African green monkey kidney cells was grown and maintained at 35oC with 5% CO2
in DMEM containing 5% FBS and gentamicin (10µg/ml). Two RUBV strains were employed:
F-Therein, a wild-type strain, will be referred to as “RUBV” while “Robo502 virus” and its
mutants are derived from an infectious cDNA clone.
Mutagenesis of the Robo502 infectious cDNA clone
Site-directed mutagenesis was done to change both prolines in a P-X-X-P-X-R motif to
alanines in the Robo502 infectious clone [19]. There are three of these motifs in the proline
hinge region, termed Motif 1, Motif 2, and Motif 3, and the following primers were used to
create proline to alanine mutations in each motif:
Motif 1 mutation: 5’ CAC CCG GCG ACG CCC CGC CGG CGC GCC GCG CAC 3’
Motif 2 mutation: 5’ CGG CAC TCC GGC CCC CGC GGC TGC GCG CGA CC 3’
Motif 3 mutation: 5’ CCG CCC CCA GCG CGC CCG CGG CAC CCC GCG C TG 3’
These mutagenic primers were combined with forward (5’CGC ATA CGT AGC CTT CCG
CGC GTG G 3’; SnaBI site underlined) and reverse (5’ GTG GGG GCG GTC CGA GAC GC
3’; Rsr II site underlined) primers in a protocol described previously [20] that introduces
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mutations using two rounds of PCR amplification in a single reaction tube. The amplification
reaction included: 50-100 ng linearized Robo502 template, 1.0 pmol internal mutagenic forward
primer (i.e. Mut1, Mut2, or Mut3),, 0.05 pmol reverse primer, 4 ul 2.5 mM dNTPs, 5 ul 10X Extaq buffer (Takara), 10 ul 5X Q solution (Qiagen), 0.5 ul Ex-taq polymerase (Takara) and 29 ul
dH2O . Briefly, the first round of PCR in which mutagenic and reverse primers were added, was
done with using the following PCR parameters: 5 cycles of 950C for 1 minute, 600 C for 30 sec,
720 C for 2 min followed by a final incubation at 72oC for 35 minutes. Following the final 35
minute incubation step, 1 µl of 125 ng/µl forward primer was added and the reaction continued
using the following protocol: 25 cycles of 960 C for 1 min, 650 C for 30 sec, 720 C for 2 min
followed by 720 C for 10 min. The extended 35 minute incubation step in the first round of PCR
helps the utilization of reverse and mutant primers so that only completed mutagenic
megaprimers are present in the final step of the PCR reaction. PCR products were purified by
phenol/chloroform extraction, precipitated with ethanol, and digested using Rsr II and SnaBI 1
restriction enzymes (NEB). The resulting fragments were gel purified (Qiagen gel extraction kit)
and reintroduced into Robo502 digested with the same restriction enzymes to replace the
corresponding wt fragment. Mutagenesis was confirmed by sequencing the entire length of the
mutagenized fragment (done by the GSU core facility). The mutant constructs were named
Mut1-Robo502, Mut2-Robo502 and Mut3-Robo502 for mutations made in the Motifs 1, 2 and 3
respectively. To make constructs with mutations in motifs 1 and 2 or Motifs 1, 2, and 3 in
combinations, a single mutant construct was used as the DNA template and mutations in the
other motifs were made sequentially using the protocol described above. These constructs were
named Mut1+2-Robo502 and MutX-Robo502 (triple mutant).
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Construction of RUBV proline-hinge-GST fusion constructs
The putative SH3-binding domain in P150, between nucleotides 2189 through 2461 of
the RUBV genome (between amino acid sequence 716 and 782), was amplified from the
Robo502 template using forward and reverse primers that contain BamH I and Cla I restriction
sites respectively: 5’GGA TCC TCC GCG GCC GCG TCA CCG CCA 3’ and 5’ ATC GAT
GTC GCT GTC TGG GTC TGC CCT 3’. The amplified PCR product was digested with BamH I
and Cla I (NEB), gel purified (Qiagen gel extraction kit) and ligated into a pEBG mammalian
expression vector (provided by Dr Tom Hobman, U. Alberta) that was digested with the same
enzymes, creating a construct termed GST-PRR/RUB. A pEBG-Mut 1+2 construct was created
using the strategy described above with the GST-PRR/RUB construct as the template, the
forward and reverse primers used to amplify the sequence introduced into PRR/RUB, and the
Mut1 and Mut2 mutagenic primers. The mutation was confirmed by sequencing. This construct
was named GST-PRR/RUB MUT 1+2.
Analysis of PRR mutations created in Robo502
Ten ug of Robo502, Mut1-Robo502, Mut2-Robo502, Mut3-Robo502, double mutant
Mut1+2-Robo502, and triple mutant MutX-Robo502 were linearized with EcoR I. The linearized
templates were purified by phenol/choloroform extraction and precipitated by addition of 0.1
volume of 3M ammonium acetate and 2.5 volume of ethanol. The precipitated DNA was
dissolved initially in 40 µl of deionized water and after determination of the DNA concentration
spectrophotometrically (O.D.260), the volume was adjusted to a final concentration of 250 ng/µl.
Each template was used in the following in vitro transcription reaction: 5 µl of 5X transcription
buffer (40 mM Tris-HCl [pH 7.5], 6 mM MgCl2, 2 mM spermidine) (Epicentre, Madison, Wis),
2.5 µl of 100 mM DTT, 1.0 µl of RNasin ribonuclease inhibitor (Promega), 1.0 µl of 25 mM
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NTPs (Amersham), 5.0 µl of 10 mM cap analogue [m7G(5′)ppp(5′)G] (New England BioLabs), 1
µl of SP6 DNA dependent RNA polymerase (25U; Epicentre, Madison, Wis.), 2 µl of 250 ng/µl
linearized template, and deionized water to make a final volume of 25 µl. The reactions were
incubated for 1 hour at 37oC and the quality of the product was ascertained by agarose gel
electrophoresis and ethidium bromide staining. Reaction mixtures were used directly for
transfection. Sixty mm culture plates of 100% confluent Vero cells were transfected with 30 µg
of an RNA transcript from the wild type or mutant constructs using Lipofectamine 2000
following the manufacturer’s recommended protocol (GIBCO BRL, Lifetechnologies). The cells
were incubated with the transfection mixture for at least 4 hours after which transfection mixture
was removed and replaced with Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with 5% fetal bovine serum (FBS) and penicillin-streptomycin (100 µg/ml). The transfected cells
were observed microscopically daily for development of cytopathic effect (CPE) and the
medium was collected one week post-transfection; this was designated Passage 0 or P0. Titers of
virus in the P0 medium were determined by plaque assay [21]. P0 medium was subsequently
passaged by infecting 60 mm plates of Vero cell lines (P1) at a multiplicity of infection (MOI) of
1 pfu/cell. Seven days post infection, the P1 medium was collected. An aliquot of the P1
medium was titered by plaque assay and total intracellular RNA was extracted from the infected
cells using Tri-Reagent (Molecular Research Center, Inc) according to the manufacturer’s
protocol. To produce a cDNA template for sequencing, reverse transcription was done using the
following protocol: 5 µl of RNA solution was boiled for 5 minutes and then incubated on ice for
5 minutes. One µl of reverse primer (5’ ATC GAT GTC GCT GTC TGG GTC TGC CCT 3’: nt
2440-2467), 3 µl of deionized water, and 4 µl of 2.5 mM dNTPs were added followed by
incubation at 65oC for 8 minutes. The reaction was cooled in ice and 4 µl of 5X first strand
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buffer (Invitrogen), 1 µl of 0.1 M DTT, 1 µl of RNasin RNase Inhibitor (Promega), and 1 µl of
Superscript III RNase H Reverse transcriptase (Invitrogen; 200U/µl) were added to make a total
reaction volume of 20 µl. The reaction was incubated at 55oC for 1 hour and the cDNA product
was subsequently used for PCR amplification. The 50 µl PCR reaction contained: 2 µl of cDNA
template, 1 µl of 200 ng/µl forward and reverse primers (5’CGC ATA CGT AGC CTT CCG
CGC GTG G 3’ and 5’ GTG GGG GCG GTC CGA GAC GC 3’; recognizing nt 1204-1229 and
3877-3897, respectively), 4 µl of 2.5 mM dNTP’s, 25 µl of GC buffer (Takara), and 0.5 µl of
Ex-Taq DNA polymerase (Takara; 5U/µl). The PCR protocol was as follows: 25 cycles of 96oC
for 1 min, 65oC for 30 sec, and 72oC for 2 min followed by and incubation at 72oC for 10 min.
The PCR product was gel purified (0.7% agarose) using a Qiagen gel extraction kit. The PCR
product was sequenced by the GSU Core Facility.
Analysis of PRR mutant RNA and DNA synthesis
Mutations in motifs 1, 2, and 1+2 were introduced into the Robo502-903 infectious clone
that yields viruses which express P150 with an HA epitope tag. Mutations were done with
mutagenic primers for motifs 1 and 2 (shown earlier) using an asymmetric 3 round PCR protocol
as described previously [22]. These manipulations were done by Dr. Wen-Pin Tzeng.
Northern blot analysis of viral genomic and subgenomic RNA produced by wild type and
mutant infectious clones was performed as described previously [23]; this analysis was
performed by Dr Wen-Pin Tzeng. RNA was extracted from cells transfected with wild type and
mutant infectious clones using Tri-Reagent (Molecular Research Center, Inc) according to the
manufacturer’s protocol. For Northern gel analysis, equivalent amounts of RNA were denatured
with Glyoxal Sample Loading Dye (Ambion, Austin, TX) for 30 min at 55°C and placed on ice
immediately. The denatured RNA was electrophoresed in a 1% agarose gel made in
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NorthernMax-Gly Gel Preparation/Gel Running Buffer (Ambion). After electrophoresis, the
RNAs were transferred to a nylon membrane (0.45-mm pore diameter; MSI, Magnagraph,
Westboro, MA) by capillary action for 2 hours using NorthernMax Transfer Buffer (Ambion) as
the transfer medium. After transfer, the nylon membrane was irradiated with a 254-nm UV
Crosslinker Lamp (Fisher Scientific, Pittsburgh, PA). The membrane was heat-sealed in a plastic
bag containing NorthernMax Prehyb/Hyb Buffer (Ambion) and prehybridized for 2 hours at
65°C. Nick-translated VR-C-E2-E1 probe (0.5 to 1 mg), which encodes the viral structural ORF
was radiolabeled by nick translation using a Nick Translation System Kit (Promega, Madison,
WI) and 50 µCi of [α-32P]dCTP (3000 mCi/mmol; New England Nuclear, Boston, MA). Half of
the nick-translated DNA probe was denatured in 50% formamide at 100°C for 5 min and added
to the blot in Prehyb/Hyb Buffer and hybridization was allowed to proceed at 65°C overnight.
After hybridization, the membrane was washed at room temperature once in Low-Stringency
Wash Solution 1 (Ambion) for 10 min and twice in High-Stringency Wash Solution 2 (Ambion)
for 15 min at 42°C. Washed membranes were wrapped in plastic wrap and exposed to Kodak Xray film at -70°C between two Cronex Lightning Plus intensifying screens.
Vero cells transfected with the wild type and mutant Robo502 constructs were also
analyzed for P150 expression at 6 hours and 3 days post-transfection. Briefly, cells were
harvested 6 hours and 3 days post-transfection using RIPA buffer (10 mM Tris-HCl pH 7.4, 150
mM NaCl, 3 mM EDTA, 1% Triton X-100, 0.1% SDS, and 0.5% DOC). An equal volume of the
post-nuclear fraction from wild type and mutant construct transfected lysates was mixed with 2X
SDS loading buffer (100 mM Tris-HCl pH6.8, 20 mM dithiothreitol, 4% SDS, 0.2%
bromophenol blue, and 20% glycerol) and resolved by electrophoresis on 6% SDS
polyacrylamide gels (6% acrylamide, 0.38 M Tris pH 8.8, 0.1% SDS, 0.1% ammonium
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persulfate). Proteins were transferred onto nitrocellulose membrane (Whatman) using 1X
transfer buffer (100 ml 10X transfer buffer [250 mM Tris, 1.92M glycine], 200 ml 100%
methanol, and 700 ml deionized water) at 100V for 1 hour in a mini-Protean II apparatus
(Biorad). Following transfer, the membranes were blocked overnight with 5% non-fat milk
powder in TBS (20 mM Tris-HCl, pH 7.5 and 175 mM NaCl). The blot was probed with mouse
anti-HA monoclonal antibody (Roche) (1:1000 dilution) in antibody dilution buffer (1% non-fat
milk powder, 0.02% sodium nitrate in TBS buffer [20 mM Tris-HCl, pH 7.5 and 175 mM
NaCl]). After addition of primary antibodies, membrane was washed three times for 10 minutes
each with 0.05% T-TBS (0.05% Tween-20 sorbitol in 1X TBS). Secondary anti-mouse antibody
(Promega) conjugated with alkaline phosphatase, diluted in antibody dilution buffer (1:7500)
was used to detect the presence of HA epitope tagged P150. Once again, membrane was washed
3 times for 10 minutes each with 0.05% T-TBS and bound antibodies were detected with a
BCIP/NBT (Roche) colorimetric assay.
Transfection with pEBG constructs and identification of interacting cell proteins
Sixty mm dishes of confluent 293-T cells were transfected with pEBG constructs using
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s protocol. Briefly, each plate
was transfected with 5-10 µg of DNA and the transfection mixture was left on the cells for at
least 4 hours before being replaced with Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum (FBS) and penicillin-streptomycin (100 µg/ml).
Three days post-transfection, the cells were washed twice with lysis wash buffer (1% Nonidet P40, 150 mM NaCl, 50 mM Tris-HCl pH 7.4, 2 mM EDTA and 150 mM sodium salicylate) and
lysed with 1% NP40 buffer (1% NP40, 150 mM NaCl, 50 mM Tris-HCl pH 7.4 and 2 mM
EDTA) and GST fusion proteins were isolated from the lysate using gluthathione sepharose 4B
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beads (Amersham Pharmacia Biotech. Inc). Briefly, 0.5 ml gluthathione sepharose 4B beads
(GST beads) were prewashed with 5 ml of phosphate buffered saline (PBS) containing 0.1%
Triton X-100, collected by low speed centrifugation and resuspended in final volume of 5 ml
PBS containing 0.1% Triton X-100. Before incubation of transfected cell lysates with the GST
beads, the lysates was precleared with an equal volume of unconjugated sepharose beads
(Sigma). Following the preclearing step, 0.5 ml gluthathione beads were incubated with 5 ml of
lysate for 3 hours at 4oC, after which the beads were washed seven times with lysis buffer (1%
NP40, 150 mM NaCl, 50 mM Tris-HCl pH 7.4 and 2 mM EDTA), and adherent proteins were
eluted with 2X SDS gel loading buffer (50 mM Tris-HCl, pH 6.8, 100 mM DTT, 2% SDS, 0.1%
bromophenol blue and 10% glycerol). The proteins were resolved by 6% or 10% SDS-PAGE
and proteins were visualized by GelCode blue staining reagent (Piercenet). Proteins of interest
(ie. those that bound to GST-PRR/RUB but not GST-PRR/RUB MUT1+2 or the GST control)
were excised with a scalpel and sent for trypsin digestion and mass-spectometry analysis to the
facility at the Morehouse School of Medicine or the Scripps Institute (TSRI Center for Mass
Spectrometry). Protein plugs were maintained in 4oC until transferred to these facilities.
Construction of hemagglutinin (HA) and c-myc epitope tagged p32 protein
The simian p32 gene in a pCB6 [24] vector was kindly provided by Dr. Tom Hobman
(University of Alberta). Two p32 constructs were made, one, with HA and c-myc epitope tags on
the N- and C- termini, respectively, and the other with a c-myc epitope on the C-terminus. The
PCR primers used to create the first construct were 5’ CGA GCT AGC CCA TGT ACC CAT
ACG ACG TCC CAG ACT ACG CTA TGC TAC CTC TGC TGC GCT GC 3’ (forward primer)
and 5’ CGA GAA TTC CTA CAG ATC TTC TTC AGA AAT AAG TTT TTG TTC CTG GCT
CTT GAC AAA ACT C 3’ (reverse primer) and to create the second construct were 5’ CTA
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GCT AGC CCA TGC TAC CTC TGC TGC GCT GCG 3’ (forward primer) and 5’ CGA GAA
TTC CTA CAG ATC TTC TTC AGA AAT AAG TTT TTG TTC CTG GCT CTT GAC AAA
ACT C 3’ (reverse primer). Nhe I and Eco RI restriction sites (underlined) were introduced for
the forward and reverse primers, respectively. Fifty µl PCR reactions contained 1 µl of pCBP6p32 DNA template, 1 µl each of 200 ng/µl forward and reverse primers, 4 µl of 2.5 mM dNTPs,
10X buffer (Takara), and 0.5 µl of Ex-Taq DNA polymerase(Takara; 5U/µl). The PCR protocol
was as follows: 25 cycles of 96oC for 1 min, 65oC for 30 sec, and 72oC for 1 min followed by an
incubation at 72oC for 10 min. The PCR product was gel purified (0.7% agarose) using a Qiagen
gel extraction kit. The PCR product was sequenced by the GSU Core Facility. The PCR products
were digested with Nhe I and EcoR I, gel purified (Qiagen gel purification kit), and ligated into
the pcDNA expression vector (Invitrogen) digested with the same enzymes. The resulting
constructs were named “pcDNA-HA-p32-myc” and pcDNA-p32-myc”, respectively.
Immunoprecipitation and Western blot analysis
Vero cells infected with Robo502-912 (with FLAG tagged P150 as described in the first
Specific Aim) and transfected with pcDNA-HA-p32-myc were lysed with RIPA buffer (10 mM
Tris-HCl pH 7.4, 150 mM NaCl, 3 mM EDTA, 1% Triton X-100, 0.1% SDS, and 0.5% DOC in
the presence of 1X mini complete protease inhibitor [Roche]). Another set of co-transfections
was done to investigate the interaction of p32 with P150 without the presence of the RUBV
capsid protein. To this end, a plasmid expressing HA-tagged P150 (CMV-P150-HA; provided by
Dr. Wen-Pin Tzeng) was employed to transfect Vero cells either alone or with pcDNA-p32cmyc. Two days post-transfection, cells were harvested and 250 µl of lysate was used for
immunoprecipitation studies. Briefly, 1 µl of mouse anti-HA, anti-c-myc monoclonal antibody
(Roche) or rabbit anti-C1QBP polyclonal antibody (CeMines) was added as appropriate. Lysate
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was incubated with the appropriate antibodies for 2 hours at 4oC. Thirty µl of agarose A beads
(Roche) were added to the mixture and incubated for an additional hour. The beads were washed
five times with lysis wash buffer (10 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.5% Triton X-100,
0.5% DOC, and 3 mM EDTA) and proteins were eluted by boiling with 60 µl 2X SDS gelloading buffer (100 mM Tris-HCl pH6.8, 20 mM dithiothreitol, 4% SDS, 0.2% bromophenol
blue, and 20% glycerol). Samples were resolved using 6% or 10% SDS-PAGE (6% or 10%
acrylamide, 0.38 M Tris pH 8.8, 0.1% SDS, 0.1% ammonium persulfate). Proteins were
transferred onto nitrocellulose membrane (Whatman) using 1X transfer buffer (100 ml 10X
transfer buffer [250 mM Tris, 1.92M glycine], 200ml 100% methanol, and 700 ml deionized
water) at 100V for 1 hour in a mini-Protean II apparatus (Biorad). Following transfer, the
membranes were blocked overnight with 5% non-fat milk powder in TBS (20 mM Tris-HCl, pH
7.5 and 175 mM NaCl). The blot was probed with mouse anti-HA monoclonal antibody (Roche)
(1:1000 dilution), mouse anti-FLAG monoclonal (Sigma)(1:1000 dilution) or rabbit anti-p32
antibody (CeMines)(1:1000) in antibody dilution buffer (1% non-fat milk powder, 0.02% sodium
nitrate in TBS buffer [20 mM Tris-HCl, pH 7.5 and 175 mM NaCl]). After addition of primary
antibodies, membrane was washed three times for 10 minutes each with 0.05% T-TBS (0.05%
Tween-20 sorbitol in 1X TBS). Secondary anti-mouse antibody (Promega) conjugated with
alkaline phosphatase, diluted in antibody dilution buffer (1:7500) was used to detect the presence
of HA epitope tagged P150. Once again, membrane was washed 3 times for 10 minutes each
with 0.05% T-TBS and bound antibodies were detected with a BCIP/NBT (Roche) colorimetric
assay.
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Immunofluorescence assay
The intracellular localization of HA-tagged P150 and c-myc-tagged p32 was analyzed by
immunofluorescence (IFA) as described previously [25]. Briefly, Vero cells were plated on 18
mm glass coverslips placed in 35 mm plates (1:25 ml dilution). Cells were transfected with
pcDNA-p32-myc and co-transfected with CMV-P150-HA or infected with Robo502-930
(expressing an HA-tagged P150). Forty eight hours post transfection, the cells were fixed with
4% paraformaldehyde in PBS for 30 min at 4oC and permeabilized with PBS-0.25% saponin for
10 min at room temperature. The coverslips were removed from the culture dishes, washed again
with PBS, and blocked by incubation with PBS, 2% BSA, 0.25% saponin for 30 min at room
temperature. Primary antibodies diluted 1:500 in PBS, 0.1% BSA, 0.25% saponin were placed
on the coverslip and incubated for 1 hour at room temperature. The primary antibodies used were
mouse anti-HA monoclonal antibody (Roche), mouse anti-c-myc monoclonal antibody (Roche)
or rabbit anti-C1QBP (CeMines) polyclonal antibody (all in 1:500 dilution). After washing three
times in PBS, secondary mouse anti-FITC antibody and rabbit anti-TRITC antibody diluted
1:1000 in PBS, 0.1% BSA, 0.25% saponin were added and incubated for 30 minutes at room
temperature. 1:1000 dilution of Hoechst was added in the reaction during the last 2 minutes of
incubation. Following washing with PBS, the coverslips were mounted on glass slides using
ProLong gold anti-fade reagent (Molecular Probes/Invitrogen). The cells were visualized using a
Zeiss Axioplan 2 imaging system at 100X magnification.
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RUBV replication in cells overexpressing p32
Vero cells were either mock transfected or transfected with pcDNA-p32-myc as
described above.

One day post-transfection, both cultures were infected with wt RUBV at an

MOI of 1. The cells were examined daily by microscopy for development of CPE and the
medium was collected each day through four days post-infection and subsequently titered by
plaque assay [21].
Results
Effect of mutagenesis of the putative SH3 binding domain in P150 on virus replication
Fig. 3.1A shows a schematic diagram of the domains within RUBV P150, including the
proline rich region (PRR) of interest. The PRR is located between amino acid residues 716
through 782 of P150. This region is also known as the hypervariable region or, HVR as it is the
most variable region of the RUBV genome among natural RUBV isolates [26]. Analysis of the
PRR using ScanProsite software (Expasy Proteomics Server) led to the identification of 3
putative Class II SH3 binding motifs with the consensus amino acid sequences “P-x-x-P-x-R”.
Fig. 3.1B shows the sequence of the PRR with the three putative SH3 binding motifs in color.
These putative SH3 binding motifs are referred to as motifs 1, 2 and 3, from the N- to Cterminus of the PRR respectively. An alignment of sequences of the PRR from viruses of 7
genotypes showed that all three motifs were highly conserved (Fig. 3.2), with the exception of
the Anam5_KOR96 strain of RUBV that had a serine instead of a proline in motif 1 (S-x-x-P-xR instead of P-x-x-P-x-R). However, this strain of virus had the ability to replicate to levels that
were similar to other strains of virus with conserved PxxPxR sequences (personal data
communication). The presence of conserved PxxPxR sequences in motif 2 of the
Anam5_KOR96 strain may possibly compensate for the lack of such conservation in motif 1.
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This may also help explain the importance of repeated PxxPxR sequences being present in one
small region of the proline rich domain.
To analyze the importance of the PxxPxR motifs in RUBV replication, proline to
alanines mutations were made in the critical proline residues of each motif, i.e. P-x-x-P-x-R to
A-x-x-A-x-R, in the RUBV infectious cDNA clone, Robo502 [19]. Mutations in the individual
motifs were named Mut1-Robo502, Mut2-Robo502 and Mut3-Robo502. In addition,
combination mutations were made in motifs 1 and 2 as well as in all three motifs and these
constructs were named Mut1+2-Robo502 and Mut-X-Robo502, respectively. In vitro transcripts
synthesized from these constructs were used to transfect Vero cells and the transfected cell
medium was collected seven days post-transfection. Cytopathic effect (CPE) is usually observed
in cells transfected with transcripts from wt Robo502 at three days post-transfection. Plaque
assays done on medium harvested from the Mut1-, Mut2-, and Mut3-Robo502 transfected cells
(passage 0 or P0) revealed that the Mut3-Robo502 transcripts produced a titer and plaque
morphology that were the same as for wt Robo502 transcripts. Also, CPE were observed on day
3 post-transfection with wt and Mut3-Robo502 transcripts. However, cells transfected with
Mut1- and Mut2-Robo502 transcripts yielded lower virus titers (1-4x104 pfu/ml) and a small
plaque morphology (see Fig 3.3). We further investigated the relative importance of these first
two domains with the combination mutants. Mut 1+2-Robo502 transcripts produced low virus
titers (1x104 pfu/ml) with a small plaque morphology, although CPE were observed on day 3
post-transfection. Mut-X-Robo502 failed to show evidence of replication.
P0 medium was subsequently passaged once in Vero cells. As shown in Fig 3.4, the P1
titer and plaque morphology as well as the development of CPE were similar for all five mutants
and wild type virus. These data suggested that reversion of the mutations in the SH3 binding
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domain may have occurred and we investigated this possibility by sequencing the virus from
infected cells. The results are shown in Table 3.1. The mutant Motif 1 present in the Mut1-,
Mut1+2, and MutX-Robo502 constructs reverted to the wt sequence and the mutant Motif 2
present in the Mut2- and MutX-Robo502 constructs reverted to the wt sequence. Interestingly,
the mutant Motif 2 in the Mut1+2-Robo502 construct did not revert. The mutant Motif 3 in
either Mut3- or MutX-Robo502 did not revert as expected from the wt phenotype exhibited by
the Mut3-Robo502 construct.
We next wanted to see if the Motif 1 or Motif 2 mutations affected synthesis of either
P150 or viral RNA. Fig. 3.5 A and B show Western blots to detect P150 at 6 hours and 3 days
post-transfection. P150 levels at 6 hours represents translation from input transcripts (a control
indicative that the construct is functional) and 3 days translation is from replicated transcripts.
One of the two Mut1+2-Robo502 clones that were tested was nonfunctional. This is one of the
reasons for the 6 hr post-transfection screening. As for the other Robo-502 mutant clones, little
difference between wt and either the single mutants or double mutant was detected. The
difference that was noted was that the translation levels of P150 from the Mut1-Robo502 clones
were slightly lower than from the wt construct. However, levels of P150 translation for the wt
and all the mutant clones were similar 3 days post transfection. A Northern blot shown in Fig
3.5C shows that levels of RNA, 3 days post transfection for the single or the double mutations,
were similar in levels to the wt. We cannot conclude that the levels of genomic and subgenomic
RNA were not affected by the mutations because reversions seem to occur rapidly and could
have accounted for the majority of RNA present.
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Identification of host proteins that bind to Motifs 1 and 2 in the P150 PRR
We next wanted to investigate the host proteins that bind to the PRR within P150. Since
mutations of Motifs 1 and 2 suppressed virus yield and also reverted to wt sequences, we
concentrated on these motifs. To do so, we made a GST fusion expression construct in which
GST was fused to the PRR. Fig. 3.6 shows a schematic diagram of the wild type construct, GSTPRR/RUB. Another construct containing mutations in both motifs 1 and 2, GST-PRR/RUB
Mut1+2 was also constructed. Fig. 3.7 shows the strategy employed to identify the host factors
that specifically bound to the PRR. Basically, proteins binding to the wt GST-PRR/RUB, but
not the GST-PRR/RUB Mut1+2 with mutations in motifs 1 and 2 were considered as candidates
(see Fig.3.8).

When this strategy was employed, a total of 4 putative host proteins were

identified, termed PRR-1, PRR-2, PRR-3, and PRR-4 (Fig. 3.8). The first protein that was
identified, PRR-4, (by Dr Powell of Morehouse School of Medicine) is p32 (score:46.11), which
was previously shown to bind to the RUBV capsid protein and for which constructs and reagents
were readily available. The other three proteins that were identified by the Mass Spec facility at
the Scripps Research Institute were PRR-1: human Mdn1 protein (Q9NU22), PRR-2: Gcn1L
protein (Q92616), and PRR-3: nucleopore complex protein Nup205 (Q92621). More than 2
peptides were identified at 95% confidence for all three of these proteins. There are no
commercially available reagents for any of these three proteins, whose functions will be
discussed later. Therefore, further characterization was confined to p32. As shown in Fig. 3.9, a
Western blot probed with anti-p32 antibodies confirmed the binding of p32 to GST-PRR/RUB
(wt) but not GST-PRR/RUB-MUT 1+2 or the GST control.
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Confirmation of the binding of host protein p32 to RUBV P150
To confirm that p32 binds to P150 as well as the GST-PRR/RUB fusion protein, a
plasmid construct expressing an HA tagged P150 was used to transfect Vero cells.
Immunoprecipitation was then performed with either anti-HA antibody, a control for pull-down
of expressed HA tagged P150, or anti-p32 antibody, to detect a P150-p32 interaction. Fig. 3.10
shows a Western blot of immunoprecipitated proteins probed with anti-HA antibody to detect
HA-tagged P150. Lane 3 shows the positive control while Lane 4 demonstrates that P150 was
co-immunoprecipitated with p32. This result indicated that the binding of P150 was authentic.
We next explored the interaction between P150 and expressed p32. For this purpose, two
p32 expression constructs were generated, one tagged on its N-terminus with an HA epitope and
on its C-terminus with a c-myc epitope (pcDNA-HA-p32-myc) and one tagged only on its Cterminus with the c-myc epitope (pcDNA-p32-myc). Vero cells were transfected with pcDNAHA-p32-myc and co-infected with Robo502-912, which carries a FLAG epitope on P150 (this
infectious clone was used in Specific Aim 1). The Fig. 3.11 Western blot shows that FLAGtagged P150 expressed from virus co-immunoprecipitated with the plasmid expressed HA-p32myc. In an experiment that employed the expressed p32-myc in cells co-transfected with HAp32-myc and CMV-P150-HA plasmid, reciprocal immunoprecipitation was demonstrated (Fig.
3.12). Specifically, HA-tagged P150 was co-immunoprecipitated by c-myc antibodies which
react with p32-myc (Panel A) while c-myc-tagged p32 was co-immunoprecipitated by anti HA
antibodies which react with HA-tagged P150. An additional protein band present above p32-cmyc in lane 4, Panel B (Fig. 3.12), may represent a modified p32 protein.
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Interaction between the two proteins was also explored by immunofluorescence. As
shown in Fig. 3.13, Panel B, plasmid expressed HA-tagged P150 (red) co-localized with
expressed p32 (green) in perinuclear foci. The same observation was made when cells were
infected with Robo502/912 which expresses an HA-tagged P150 (Fig 3.13, Panel A) and thus
interaction occurs whether P150 is expressed in a plasmid or virus context.
Finally, in light of our earlier results that mutations in motifs 1 and 2 in the GSTPRR/RUB fusion abolished the binding of p32, the finding that led to identification of p32 as a
P150 pairing partner, we introduced the same motif 1 and 2 mutations into the CMV-P150
expression contruct. Vero cells were co-transfected with pcDNA-p32-myc and either CMV-P150
or CMV-P150-MUT1+2 vector DNA. As shown in Fig. 3.14, anti-c-myc antibody coprecipitated P150 expressed by CMV-P150 (Lane 4) but not mutant P150 expressed by CMVP150-MUT1+2 (Lane 6). Thus, P150-p32 binding is mediated by the PRR region of P150.
Investigation of the function of p32 in the RUBV life cycle
Evidence obtained with virus that had mutations in the PxxPxR motifs in the PRR
indicated that while this region was not necessary for virus RNA synthesis and concomitant
protein production, these mutations suppressed virus titers and revertants were rapidly generated.
We thus wanted to look at the physiological relevance of the p32-P150 interaction as means of
further studying this phenotype. Previous attempts in our lab to knockdown p32 using siRNA
were unsuccessful (H. Mousa, unpublished observations) and another lab also did not have
success (T. Hobman, personal communication). We therefore tested the effect of overexpression
of p32 on RUBV replication [27]. Vero cells transfected with pcDNA-p32-myc were co-infected
with RUBV. Approximately 80% of cells were successfully transfected (data not shown). As
shown in Fig. 3.15, p32-myc expression was maintained through 4 days post-transfection,
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whether the cells were infected or not, and the localization of expressed p32-myc by
immunofluorescence (Fig. 3.16) was comparable to endogenous p32 as shown in Fig. 3.13.
However, as shown in Table 3.2 the increased levels of p32 in the transfected cells mildly
increased the levels of virus replication in the first two days post infection, compared to mocktransfected cells. These data taken together would suggest that p32 may be involved in the ability
of the virus to replicate because the presence of an increased amount of host factor did lead to an
increase in the amount of virus production, especially early times of infection.
Discussion
In this study, we investigated the PRR region of RUBV P150, spanning from amino acids
716 to 782, that contained a putative SH3 binding domain. We wanted to know if the three P-XX-P-X-R consensus Class II SH3 binding motifs of interest that were predicted in this region and
that were conserved despite the variability of the region among viral isolates, were of any
consequence to the RUBV life cycle. In order to do this, we made proline to alanine mutations,
ie P-X-X-P-X-R to A-X-X-A-X-R, in the three putative SH3 binding motifs (we called these
Motifs 1, 2 and 3) in the RUBV infectious clone, Robo502. After transfection of Vero cells, it
was apparent that the Motif 1 and 2 mutants negatively affected virus replication. First, the cells
transfected with these mutants did not exhibit CPE. Usually, CPE occurs on day 3 following
transfection with wt Robo502. Secondly, viral RNA mutated in either of the first two motifs
produced virus titers that were at least 2 logs lower compared to wild type RNA. Thirdly, the
Motif 1 and 2 mutants produced small plaque morphology. In contrast, mutations made in the
third predicted SH3 binding motif yielded a phenotype similar to wild type, indicating that this
predicted motif was not of importance to the replication of the virus. A double mutant of motifs
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1 and 2 exhibited a phenotype similar to the individual motif 1 and 2 mutants while a triple
mutant of all three motifs produced neither CPE nor plaques following transfection.
Culture medium from transfection plates was passaged to see if revertants would arise.
P1 medium from infections with viruses with mutations in motif 1, motif 2, or motifs 1+2
displayed a similar titer and plaque morphology as did wild type virus. Virus with the triple
mutation also displayed a wild type phenotype after the first passage. These observations
prompted us to analyze the sequences of the passage 1 viruses. As expected, we found that
individual mutations made in motifs 1 and 2 had reverted to the wild type sequence as had both
these motifs in the triple mutant. In the double motif 1+2 mutant, only motif 1 reverted to wild
type. However, mutations made in motif 3, either in the individual mutant or in the triple mutant,
did not revert to the wild type sequence. These data strongly suggested that the motifs 1 and 2 of
the predicted SH3 binding domain were under positive selection pressure and were important for
the virus life cycle.
Next, we looked at translation of P150 following transfection to see if the mutations in
the region of interest affected levels of protein translation using Western blot analysis of lysates
collected 6 hours and 3 days post-transfection with the individual motif 1 or motif 2 mutants or
the double mutant. The first time point represents translation of the input transcript while the
second time point represents translation from replicated transcripts. As mentioned in the results,
levels of P150 translation of viral RNA with mutation in motif 1 was lower compared to wt at 6
hours post-transfection. However, the result of the 3 day time point indicated wt-level replication
for the genome RNA. Also, Northern blot analyses of the intracellular genomic and subgenomic
RNA levels showed no differences between the mutants and wt. These data do not necessarily
indicate that the mutations had no effect on the production of subgenomic or genomic RNA. As
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revertants seem to occur rapidly, it is possible that by 3 days post-transfection, the majority of
the genomic and subgenomic RNA accumulated were apparently reverted (wt). To accurately
evaluate the effects of mutations on levels of viral genomic and subgenomic RNA production,
the experiment has to be approached in two ways. One way is to look at RNA levels at times that
are earlier than 3 days post-transfection, having an appropriate control for the decay of input
transfected infectious clone RNA. Secondly, instead of point mutations, proline rich sequences
of interest could be deleted to avoid the occurrence of revertants. Such experiments would
provide an accurate assessment of the effect of the PxxPxR sequences of P150 RUBV on virus
replication.
The role of proline rich domains in the proteins of other viruses has been associated with
virus maturation and release [28, 29] as well as pathogenicity [17]. The C-terminus of the Gag
protein of HIV, for example, has a proline rich region (PxxP motif), called the P6 domain that
has been shown to play an important role in virus budding and release [30]. Mutations made in
this region resulted in a 20 fold decrease in virus production. The process of virus budding and
release is known to occur through interaction of virus components with a variety of host proteins
mediated by PxxP motifs. A protein called Tsg101 is a host protein involved in the sorting of
proteins via the endosomal sorting complex required for transport (ESCRT) [31]. Binding of
Tsg101 to the PxxP (Pro-Thr-Ala-Pro) domain of HIV-1 Gag protein has been shown to be
critical for the proteolytic processing of Gag and virus particle release [32, 33]. The Ebola virus
Vp40 matrix protein (EbVp40) was also shown to contain a PxxP motif that is important for
virus particle egress through interaction with Tsg101 [34]. We know from previous studies that
RUBV P150 interacts with the capsid structural protein. It is possible that the PRR domain
within P150 mediates the interaction with capsid protein via host cellular factors (e.g. p32 binds
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to both) so that virus assembly and release can occur. The disruption of this interaction by
mutagenesis of the P150 PxxP motifs could have caused the observed decrease in virus release.
Alternatively, a host factor binding to P150 may be important in transport of the newly replicated
virus RNA to the site of virion assembly.
Viral SH3 binding domains are also important in regulating signaling pathways that
promote virus replication. For example, in a recent study involving influenza A virus, SH3
binding domains were found in the NS1 nonstructural protein [18], an important virulence factor.
An association of the NS1 SH3 binding domain with Crk/CrkL proteins was found. These
proteins contain SH3 domains and have been implicated in a variety of signaling pathways,
including the PI3K pathway involved in cell survival. In this study, the researchers found
through mutagenesis of the NS1 region responsible for binding to the Crk/CrkL proteins that
interferon suppression mediated by NS1 was not affected, but rather PI3K signaling was not
enhanced. Activation of PI3K signaling had been previously shown to enhance influenza A virus
replication and decrease apoptosis in infected cells [15]. Therefore, this study provides a
mechanism that is mediated through the SH3 binding domain of NS1 protein that is important for
the replicative capacity of the virus and similar interactions between P150 and signaling
pathways could be important in the RUBV life cycle.
Aside from interaction with host cellular factors that affect virus maturation via assembly
and release or cell signaling pathways that promote virus replication, it has been extensively
shown that PxxP motifs and their interaction with SH3 domains play a role in the development
of virus pathogenesis. The HIV Nef protein is one such example of a virus protein that contains a
PxxP consensus sequence. Nef is important for several functions. Firstly, it is important for
enhancing infectivity of virus particles [14, 35, 36]. Secondly, it has a role in the regulation of
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CD4 and MHC I expression on the plasma membrane [37, 38]. Thirdly, it has been shown to be
involved in cellular signaling [39]. Nef protein is important for the pathogenesis of the virus as it
is required for the development of AIDS in humans and rhesus macaques [40, 41]. In one study
on the Nef PxxP consensus sequence, it was found that it binds to a member of the Src kinase
family, Hck protein, a form of tyrosine kinase which is involved in cellular signaling [13, 42].
The interaction of Nef protein with Hck was found to be important for the infectivity of HIV-1.
Hepatitis C virus (HCV) nonstructural protein NS5A also has class II PxxP consensus
sequences in its C-terminus. NS5A is an important virus protein involved in IFN-α resistance
[43, 44] and replication in general [45-47]. The PxxP sequence of NS5A was shown to bind
Amphiphysin II (Bin1) in two different studies [48, 49]. This interaction was mediated through
an SH3 domain present in the C-terminus of the Bin1 protein. Bin1 is a nucleocytoplasmic cmyc interacting protein associated with apoptosis [50] and clathrin mediated endocytosis [51].
According to these studies, mutations in the SH3 binding domain of NS5A resulted in a virus
that was not infectious in chimpanzees and also not able to overcome Bin1 induced apoptosis.
These data point to the importance of this particular SH3 binding domain in viral pathogenesis.
The importance of the viral SH3 binding domains in pathogenesis of a virus was also
shown in studies of the PxxP motif of the gp30 protein of bovine leukemia virus (BLV) [17]. In
this study, infection of sheep with viruses having mutations in the PxxP motif of the BLV gp30
transmembrane protein did not lead to tumorigenesis while sheep infected with the wild type
virus died of leukemia and lymphoma. Although all of the animals seroconverted at
approximately the same time, only those transfected with the wild type virus developed tumors,
revealing the importance of the SH3 binding domain in the development of tumors in animals
infected with this virus. Data from other viruses suggest that there is a possibility that RUB P150
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through interaction with host factors via its SH3 domain is important for the development of
pathogenesis of the virus. However, the lack of an animal model for RUB would make it difficult
to further study this hypothesis.
Since we had shown that the predicted SH3 binding domains 1 and 2 of RUB P150 are of
importance to the virus life cycle, we next wanted to identify the potential binding partners of
these domains. Binding experiments using the PRR of P150 fused to GST as bait led to
identification of four putative host cellular interacting proteins, namely the p32 protein (gC1qR),
human Mdn1 protein, Gcn1L protein and nucleopore complex protein Nup205. The human
Mdn1 protein is a homolog of the yeast Rea1 protein that is involved in ribosome biogenesis
[52], Gcn1L protein has protein binding and ribosome binding domains that are involved in
regulation of translation [53] and the Nup205 protein is part of the nuclear pore complex and,
like other members of the nuclear pore complex, is involved in regulating permeability of the
nuclear membrane [54]. Interestingly, studies have shown that some RNA viruses target
members of the nuclear pore complex to disrupt normal trafficking of host RNA and proteins
[55], a mechanism that probably targets host cell protein synthesis. In this regard, RUBV does
not exhibit a marked shutdown of either cell RNA or protein synthesis [56]. The interaction of
these three host factors with P150 was not investigated as there were no commercially available
reagents to do so. We decided to investigate the interaction of p32 with RUB P150 as there was
precedence for the binding of this protein to RUB capsid protein [24, 57] as well as to proteins of
other viruses [58-60]. It was therefore quite plausible that the p32 host protein in conjunction
with both P150 and capsid (both p32 interacting partners) is involved in the regulation of the
viral life cycle. Furthermore, reagents for p32 were commercially available to facilitate our
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studies. These reagents were first used to confirm that p32 bound to wt GST-PRR/RUBV, but
not GST-PRR/RUV MUT 1+2.
We next wanted to ensure that p32 bound to the complete P150 protein and did so by
expressing P150 in Vero cells and showing that it was co-immunoprecipitated by anti-p32
antibodies. Finally, an immunofluorescence assay using anti-p32 antibodies showed colocalization of P150, either in virus-infected cells or cells transfected with the P150 expression
construct, with endogenous p32. In virus infected cells, the foci of P150 colocalized with p32,
but there were also cytoplasmic punctae of p32 not associated with P150. In P150-transfected
cells, P150 fibers were formed and colocalization of p32 with these fibers was observed.
For subsequent experiments, we expressed p32 protein from a pcDNA expression vector
with epitopes at the N and/or C termini of the protein. The construct design was based on the
precursor form of p32 (282 amino acids in length) that had 73 amino acids at the N-terminus
containing a mitochondrial targeting sequence [61]. We designed two constructs, one that had a
HA epitope at the N-terminus and a c-myc epitope at its C-terminus and one that only had the cmyc epitope at the C-terminus. Anti-HA antibodies were used to co-immunoprecipitate P150 in
lysates of virus-infected cells co-transfected with the HA-p32-myc construct. However, the
amount of P150 that was pulled down was low. Three factors could have contributed to this
observation. Firstly, there were low levels of RUB P150 present in these cells because it was
expressed from the virus; secondly, an HA epitope at the N terminus of p32 could be masking
the interaction site for RUB P150; and thirdly, the retargeting of p32 to a different site in the
cytoplasm because of the presence of a tag on the N terminus that contains the mitochondrial
targeting signal. P32 in this new site may not be easily accessible for the binding to RUB P150.
The retargeting of p32 to a site other than its usual one due to the addition of an epitope tag at
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the N-terminus was shown by a group of cell biologists in the UK [62]. Thus, we used Cterminally

c-myc-tagged

p32

construct

for

the

remainder

of

the

experiments.

Immunofluorescence assay of this construct showed localization that was comparable to the
distribution of endogenous p32 as was described by other researchers [62, 63]. We first used the
pcDNA-p32-myc construct to demonstrate reciprocal co-immunoprecipitation between p32 and
P150 in cells co-transfected with CMV-P150 and pcDNA-p32-myc.
In order to try to understand the role that p32 is playing in the RUBV life cycle, we
looked at the effects of p32 overexpression on virus titer based on an earlier report that
overexpression of p32 in Vero cells enhanced RUBV replication [27]. In that study, researchers
overexpressed p32 in Vero cells and looked at the levels of RUBV capsid protein as an
indication of levels of infection because they were not able to measure production of virus by
plaque assay. They found that cells overexpressing p32 had significantly higher levels (about
75% higher that control cells not overexpressing p32) of RUBV capsid as evident through
Western blot and IFA analysis. Their analysis was done 3 days post-infection. For our studies,
Vero cells were first transfected with pcDNA-p32-myc and then infected the following day with
RUBV. Culture medium was collected each day post-infection for four days and virus titer was
determined. A mild increase (about ½ log) in viral titers were observed between Vero cells and
pcDNA-p32-myc transfected cells, especially on days 1 and 2 post-infection. The expression of
p32 over the duration of the experiment was further confirmed by Western blot. Based on our
findings, we cannot make comparisons with the earlier report [27] because RUBV replication in
that report was measured by accumulation of intracellular capsid protein, not plaque assay.
While higher viral titers during the first 2 days of virus infection in cells overexpressing p32
could be related to the finding that RUBV capsid is increased in amount, further studies need to
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be done especially at earlier infection times, before we can draw those conclusions. Another
observation that was made in infected cells overexpressing p32, was that CPE was somewhat
stronger than in the RUBV-infected Vero cells. RUBV-induced CPE in Vero cells is due to
induction of apoptosis [64, 65] and a propidium iodide-based assay to detect apoptotic cells
indicated an increase of sub-G0 phase cells in p32 transfected vs the untransfected Vero cell
cultures infected with RUBV (data not shown). It has been shown that p32 is associated with
induction of apoptosis [66, 67].
Our results do not prove that the phenotype of viruses with mutations in Motifs 1 and 2 in
the P150 PRR (ie. little effect on RNA synthesis or NSP expression, but reduced titer and rapid
reversion) are due to abrogated binding of p32 and thus the function of p32 in the RUBV life
cycle, if any, is not clear, but potential functions may be speculated on based on our findings and
previous work on p32 and its association with other viruses. The p32 protein is known by other
names: gC1Qr (globular heads of the C1q protein receptor) and HABP (the hyaluronic acidbinding protein). The diversity in the names of this protein are an indication of the multiple
functions that this protein is thought to have. Historically, the p32 protein was isolated as part of
the ASF/SF2 human splicing factor complex in the nucleus of HeLa cells [68]. In a later study
[69], it was suggested that p32 regulated the activity of the ASF/SF2 complex by acting as an
inhibitor to control RNA binding activity. This was shown to be achieved through inhibition of
ASF/SF2 phosphorylation. In addition to its function in the nucleus, p32 was later shown to be a
resident of the mitochondria [63] and in this study it was found that p32 was primarily a resident
in mitochondria. Additionally, mutations of genes homologous to p32 in yeast showed that p32
was involved in maintaining oxidative phosphorylation. Aside from this study, earlier work on
p32 showed that it functioned as a phosphate translocator in mitochondria [70, 71]. Another
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report that supports the localization of p32 in the mitochondria was one that showed the binding
of mitochondrial precursor proteins to p32 [61]. These researchers showed that proteins destined
for the mitochondria were bound to p32 through a mitochondrial signal sequence which allowed
p32 to act as an import receptor. It was later shown that p32 does indeed contain a 73 amino acid
mitochondrial targeting sequence at the N-terminus that is efficiently removed by proteolytic
processing [63]. P32 was also identified as a potential binding partner for a variety of proteins
that would have to bind p32 at the cell surface. Examples of some of these proteins are C1
complement component protein, C1g [72], and other extracellular plasma proteins involved in
coagulation such as kininogen [73], and factor XII [74]. All these findings suggests that p32 is a
multifunctional protein.
The interaction of p32 with proteins from a variety of viruses, and even bacteria, has
been documented. For instance, the interaction of p32 with the HIV Tat and EBV EBNA-1
proteins was shown to be important for enhancement of transcriptional activity [58, 75].
Additionally, p32 was shown to bind to the HIV Rev protein [60], which facilitates nucleus to
cytoplasm transport of unspliced HIV RNA, and also to the adenovirus core protein that
potentially mediate the shuttling of adenoviral DNA into the nucleus [59, 76]. From these studies
it seems that p32 is involved in two main kinds of function: RNA-related regulatory functions
and shuttling of RNA. One interaction of particular interest to us is the interaction between p32
and the RUBV capsid protein [24, 57]. This interaction was hypothesized to be involved in the
reorganization and distribution of [25] mitochondria to cluster around CPVs, which is a unique
hallmark of RUBV infection [25] . This reorganization of mitochondria was thought to perhaps
serve as a source of energy for the RNA synthesis process. It was also hypothesized that the
reorganization of mitochondria by capsid may facilitate the incorporation of cardiolipin into the
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mature virion [77]. In addition, disruption of the p32 binding site on the capsid protein leads to
decreased levels of virus production, as measured by plaque assay, and a specific decrease in the
synthesis of the subgenomic RNA [57]. However, the binding sites that were mutated were two
arginine clusters that have also been shown to bind the viral RNA. The capsid protein is
important in both modulating the ratio of genomic to subgenomic RNA [57] and in capsid
formation and thus these capsid mutations could have affected these functions independent of
binding p32.
As for the association of p32 with RUB P150, two possible functions that could be
mediated by this interaction are virion assembly and virus pathogenesis. Concerning virus
assembly, P150 forms a fibrous network in cells [78] that could be involved in helping virus
particle movement out of the infected cell and our data indicate that p32 is recruited to this
network. As discussed earlier, a variety of host proteins found in the extracellular matrix have
been shown to bind to p32. In a study that used immunogold electron microscopy to evaluate
subcellular localization of p32 [79] in various culture cell lines, apart from detecting the
presence of p32 in the mitochondria, this protein was also found on cell surface of pancreatic
acinar cells. P32 was also found in zymogen granules, condensing vacuoles and endoplasmic
reticulum. In another experiment that attempted to track the localization of p32 after attaching
epitope tags to either the N or C termini of the protein, researchers made the observation that
masking the mitochondrial targeting signal (MTS) redirected p32 either to the ER or to the cell
surface [62]. They hypothesized that masking the N terminus MTS caused the redirection of the
protein to these other locations in the cells, possibly explaining the ambiguity in the variety of
locations that p32 is found. It is possible that the binding of p32 to both P150 and capsid protein
could functionally be important during virus assembly. However, further studies have to be done
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to test this hypothesis. One study that could be done is to look at the effect of P150 PxxP mutants
on the localization of P150 and on the co-localization of P150 with p32.
Two recent studies suggests a role for p32 in reducing mitochondrial membrane potential
and inducing apoptosis [66, 67]. Our previous studies have shown that P150 is the determinant of
cytopathogenicity in Vero cells [21] and recent studies in our lab showed that RUB P150 alone
can induce apoptosis. Interestingly, induction of apoptosis is suppressed in the presence of the
capsid protein (unpublished data). It is therefore possible that the interaction of P150, capsid
protein, and p32 modulates the induction of apoptosis in infected cells.
In conclusion, we found that mutations in the first 2 PxxPxR motifs of P150 led to a 2 log
decrease in viral titers after passage 0. Additionally, the mutations in motifs 1 and 2 reverted to
wt sequence by the first passage. As for the effects of mutations on levels of genomic and
subgenomic RNA, we did not see significant differences 3 days post-transfection of wt and
mutant viral RNA. However, with the rapid rate of reversion observed, genomic and subgenomic
RNA levels should probably be analyzed at earlier times post-transfection. As for the studies
involving host cellular factors that bind to the proline rich region, we confirmed the binding of
cellular p32 to motifs 1 and 2 of P150. Overexpression of p32 in cells infected with RUBV led to
½ log increase in viral titers at earlier times post-infection. Further studies need to be done to
elucidate the actual role of p32 in the RUBV life cycle. In addition to p32, 3 other cellular
proteins were identified, but further analyses of these interactions with P150 were not pursued.
More host proteins may associate with the proline region of P150, but our technique of
interacting protein detection led to the identification of host proteins that were present in higher
abundance.
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Figure 3.1A. RUBV genomic organization and domains within the P150 nonstructural
protein.
A) Rubella virus genome organization showing the two ORFs and five nonstructural and
structural proteins encoded by the virus. B) Domains present within the P150 nonstructural
protein (1301aa): MT (methyl/guanylyltransferase), nt 230-439 (70aa); PPR (polyproline
region), nt 2120-2440 (107aa); XD (X domain, adenosyl-ribose phosphatase), nt 2492-2998
(169aa); NP (nonstructural protease), nt 3041-3940 (300aa).

Figure 3.1B. Predicted consensus SH3 binding motifs within the P150 PRR.
The sequence of the PRR within P150 (aa 716-782) is given. Motifs 1 through 3 are predicted class
II SH3 binding domains with PxxPxR consensus sequences.
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Figure 3.2. Multiple sequence alignment of proline rich region of RUBV from 7 genotypes.
Alignment of 14 different genotypes of RUBV reveals high levels of conservation of the 3
P-x-x-P-x-R sequences (highlighted in green). This alignment was performed by Dr Yumei
Zhou.
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Figure 3.3. Viral titers in culture fluid from transfection plates and plaque morphologies.
Vero cells were mock-transfected or transfected with transcripts from the wild type infectious
clone (Robo502) or Robo502 derivatives containing proline to alanine mutations in the
predicted SH3 binding motifs 1, 2 and/or 3 (the construct with mutations in all three motifs
was designated as MutX). The transfected cells were observed daily for CPE (the day on
which CPE was first observed is indicated) and the transfected cell medium (designated as
“passage 0” or “P0”) was collected on day 3 post-transfection and titered by plaque assay.
The virus titer in each P0 culture fluid and the highest dilution plate on which plaques were
observed is shown for visualization of plaque morphology.

109

Figure 3.4. Viral titers in culture fluid from infected plates after passage 1 and plaque
morphologies.
Vero cells were infected with P0 culture fluids (see Fig. 3.3) and observed daily for CPE (the
day on which CPE was first observed is indicated). The culture medium (designated as
“passage 1” or “P1”) was collected on day 3 post-infection and titered by plaque assay. The
virus titer in each P1 culture fluid and the highest dilution plate on which plaques were
observed is shown for visualization of plaque morphology.
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Table 3.1. Sequence of Robo502 PxxPxR motif mutants after one passage in Vero cells.

1

Construct1

Sequence1

Wild type Robo502

Wild type sequence

Robo502-MUT1

Reverted to wild type sequence

Robo502-MUT2

Reverted to wild type sequence

Robo502-MUT3

No revertants; mutation still at motif 3

Robo502-Mut1+2

Motif 1 reverted to wild type sequence

Robo502-MUTX

Motif 1 and 2 reverted to wild type sequence; mutation still at
motif 3

Vero cells were transfected with the indicated Robo502 constructs. The transfected culture medium was
harvested and passaged once in Vero cells. The PRR domain of passaged virus was sequenced.

111

Figure 3.5. P150 and RNA production by Robo502 wt and mutant RNA.
(A and B). Vero cell were transfected with transcripts from the wild type and mutant Robo502
–930 infectious cDNA clones which contain an HA epitope-tagged P150. Viral RNA
transcript from 2 clones of each mutant was used. Lysates of the transfected cells were made
at 6 hours and 3 days post-transfection. Proteins in the cells lysates were resolved by 6%
SDS-PAGE followed by Western blot analysis using mouse monoclonal anti-HA antibody.
(C) Vero cells transfected with transcripts from wild type and mutant Robo502-930 infectious
cDNA clones were harvested 3 days post-transfection and total cell RNA was extracted and
resolved on a 1% agarose gel followed by Northern blotting probed with VR-C-E2-E1 (see
Materials and Methods)
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Figure 3.6. GST-PRR expression vector.
The P150 PRR was cloned into the pEBG mammalian expression vector between the Bam HI
and Cla I restriction sites as shown to produce a GST-PRR fusion protein when expressed in
transfected 293T human embryonic kidney cells.
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Figure 3.7. Schematic of procedure used to identify proteins interacting with GST-PRR
fusion protein.
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Figure 3.8. Resolution of cell proteins interacting with pGST-PRR and pGST-PRR-MUT 1+2
fusion proteins.
293-T cells were transfected with the wild type (pGST-PRR/RUB (lane 1) or mutant (pGSTPRR/RUB-Mut1+2)(lane 2) GST fusion protein expression constructs and lysates were
prepared 68 hours post-transfection and incubated with gluthathione sepharose 4B beads.
Bound proteins were eluted and resolved by 10% SDS-PAGE (Panel A) or 6% SDS-PAGE
(Panel B). Proteins that bound to the wt fusion protein but not to the mutant fusion protein
(PRR1-PRR4) were excised and identified by trypsin digestion and mass spectroscopy.
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Figure 3.9. Interaction of GST-PRR fusion proteins with host cell protein
p32/HABP1/gC1qR.
293-T cell lines were transfected with pEBG, wild type GST-PRR/RUB or mutant GSTPRR/Mut1+2 vector DNA. Three days post-transfection, the cells were lysed, and the GST or
GST-PRR proteins and interacting cell proteins were isolated on glutathione sepharose 4B
and resolved by 10% SDS-PAGE followed by Western blotting probed with polyclonal rabbit
anti-p32 antibody. As can be seen, p32 interacted with the wt GST-PRR/RUB fusion protein,
but not the GST-PRR/Mut1+2 fusion protein or the control GST protein. Additional bands
below arrow indicating p32 could be degradative products of p32.
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208 kDa

Figure 3.10. Co-immunoprecipitation of expressed P150 with endogenous p32.
Vero cells were either mock-transfected (lanes 1 and 2) or transfected with a plasmid vector
(CMV-P150-HA) expressing an HA epitope-tagged P150 (lanes 3 and 4) and lysed two days
post-transfection. The lysates were immunoprecipitated with monoclonal mouse anti-HA
antibody or rabbit anti-P32 antibody followed by 6% SDS-PAGE and Western blot probed
with anti-HA antibody. As can be seen, in the CMV-P150-HA-transfected cells, HA-tagged
P150 was immunoprecipitated by both anti HA (control) and anti p32 antibody.
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Figure 3.11. Co-immunoprecipitation of expressed p32 and P150 in RUBV-infected cells.
Vero cells were mock-transfected (lanes 1 and 3) or infected with Robo502-912 (which
expresses a FLAG-tagged P150) and transfected with HA-p32-c-myc (which expresses p32
N- and C-terminally tagged with HA and c-myc epitopes, respectively). Two days postinfection/transfection cells were lysed and samples were immunoprecipitated using
monoclonal mouse anti-FLAG or mouse anti-HA antibody followed by 6% SDS-PAGE and
Western blot probing with monoclonal mouse anti-FLAG antibody. As can be seen, FLAGtagged P150 was immunoprecipitated with both anti-FLAG (control) and anti-HA antibody.
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37 kDa

Figure 3.12. Reciprocal co-immunoprecipitation of expressed P150 and p32.
VERO cells were either mock transfected or co-transfected with CMV-P150-HA, which
expresses an HA-tagged P150, and p32-c-myc, which expresses a C-terminal c-myc tagged
p32. Two days post-transfection, the cells were lysed and immunoprecipitated with
monoclonal mouse anti-HA or anti-c-myc antibody. Following resolution by 6% and 10%
SDS-PAGE, respectively, Western blot analysis was performed using anti-HA (Panel A) or
anti-c-myc (Panel B) antibodies. As can be seen, anti HA and anti-c-myc antibodies both
immunoprecipiated HA-tagged P150 (Panel A) and, reciprocally, anti c-myc and anti-HA
antibodies both immunoprecipitated c-myc tagged p32 (Panel B). Additional band above
p32-c-myc in lane 4 may represent a modified p32.
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Figure 3.13. Colocalization of endogenous p32 with P150.
A) Vero cells were infected with Robo502-912, which expresses a FLAG epitope tagged
P150. Twenty four hours post-infection, the cells were processed for IFA using mouse antiFLAG antibody (green) and rabbit anti-p32 antibody (red). B) Vero cells were transfected
with CMV-P150-HA. Twenty four hours post-infection the cells were processed for IFA
using mouse anti-HA antibody (red) and rabbit anti-p32 antibody (green). Hoechst Dye was
used to stain nuclear DNA (blue). The cells were visualized using Zeiss Axioplan 2
imaging system at 100X magnification.
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Figure 3.14. Lack of co-immunoprecipitation of p32 with a P150 that has mutated PxxPxR
motifs.
Vero cells were mock transfected (lanes 1 and 2), co-transfected with CMV-P150-HA and
p32-c-myc (lanes 3 and 4) or co-transfected with CMV-P150-HA/Mut1+2 and p32-c-myc
(lanes 5 and 6). Two days post-transfection, the cells were lysed and the lysates were
immunoprecipitated using monoclonal mouse anti-HA (lanes 1, 3, and 5) or mouse anti-c-myc
(lanes 2, 4, and 6) antibody. The immunoprecipitated proteins were resolved by 6% SDSPAGE followed by Western blot analysis probing with anti-HA antibody. As can be seen, wt
expressed P150 was co-immunoprecipitated by anti-c-myc antibody while the mutant
expressed P150 was not.

121

Figure 3.15. Expression of transfected p32-c-myc.
Vero cells were mock transfected or transfected with p32-c-myc and then infected the
next day with RUBV, or just transfected with p32-c-myc. On days 1 through posttransfection, cells were lysed and the lysates were resolved by 10% SDS-PAGE
followed by Western blot analysis probed with mouse monoclonal anti-c-myc antibody.
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Figure 3.16. Intracellular localization of expressed c-myc tagged p32.
Vero cell lines were mock transfected or transfected with pcDNA-p32-c-myc. On days 2 and 3 posttransfection, cells were processed for IFA using anti-c-myc antibody (green). Hoechst Dye was used
to stain nuclear DNA (blue). The cells were visualized using a Zeiss Axioplan 2 imaging system
under 100X magnification.
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Table 3.2. RUBV replication in Vero cells over-expressing p32.

1

Vero cells were mock-transfected or transfected with pcDNA-p32-myc and then infected with
RUBV (MOI = 1 pfu/cell) the next day. The culture medium was harvested daily and titered by
plaque assay. This experiment was done twice and the titers are averaged.

.

